메뉴 건너뛰기




Volumn 2012, Issue 7, 2012, Pages

Citalopram versus other anti-depressive agents for depression

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CYCLOHEXANOL DERIVATIVE; MORPHOLINE DERIVATIVE; PAROXETINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

EID: 84866456643     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006534.pub2     Document Type: Article
Times cited : (50)

References (407)
  • 2
    • 85203272486 scopus 로고    scopus 로고
    • A double-blind, placebo controlled, fixed-dosage study comparing the efficacy and tolerability of paroxetine CR and citalopram to placebo in the treatment of Major Depressive Disorder with anxiety
    • Unpublished study. A double-blind, placebo controlled, fixed-dosage study comparing the efficacy and tolerability of paroxetine CR and citalopram to placebo in the treatment of Major Depressive Disorder with anxiety. www.gsk-clinicalstudyregister.com.
    • www.gsk-clinicalstudyregister.com
  • 3
    • 11144277799 scopus 로고    scopus 로고
    • Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram
    • Allard P, Gram L, Timdahl K, Behnke K, Hanson M, Sogaard J. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram. International Journal of Geriatric Psychiatry 2004;19(12):1123-30.
    • (2004) International Journal of Geriatric Psychiatry , vol.19 , Issue.12 , pp. 1123-1130
    • Allard, P.1    Gram, L.2    Timdahl, K.3    Behnke, K.4    Hanson, M.5    Sogaard, J.6
  • 4
    • 0022448068 scopus 로고
    • Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicentre study
    • Andersen J, Bech P, Benjaminsen S, Bjerre M, Bojhlm S, Christensen P, et al. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicentre study. Psychopharmacology 1986;90:131-8.
    • (1986) Psychopharmacology , vol.90 , pp. 131-138
    • Andersen, J.1    Bech, P.2    Benjaminsen, S.3    Bjerre, M.4    Bojhlm, S.5    Christensen, P.6
  • 5
    • 0023835170 scopus 로고
    • The Diagnostic Melancholia Scale (DMS): dimensions of endogenous and reactive depression with relationship to the newcastle scales
    • Bech P, Allerup P, Gram LF, Kragh-Sorensen P, Rafaelsen OJ, Reisby N, et al. The Diagnostic Melancholia Scale (DMS): dimensions of endogenous and reactive depression with relationship to the newcastle scales. Journal of Affective Disorders 1988;14(2):161-70.
    • (1988) Journal of Affective Disorders , vol.14 , Issue.2 , pp. 161-170
    • Bech, P.1    Allerup, P.2    Gram, L.F.3    Kragh-Sorensen, P.4    Rafaelsen, O.J.5    Reisby, N.6
  • 7
    • 8944224539 scopus 로고    scopus 로고
    • Screening and treating depressed patients A comparison of two controlled citalopram trials across treatment settings: hospitalized patients vs patients treated by their family doctors
    • Fuglum E, Rosenberg C, Damsbo N, Stage K, Lauritzen L, Bech P. Screening and treating depressed patients A comparison of two controlled citalopram trials across treatment settings: hospitalized patients vs patients treated by their family doctors. Acta Psychiatrica Scandinavica 1996;94(1):18-25.
    • (1996) Acta Psychiatrica Scandinavica , vol.94 , Issue.1 , pp. 18-25
    • Fuglum, E.1    Rosenberg, C.2    Damsbo, N.3    Stage, K.4    Lauritzen, L.5    Bech, P.6
  • 8
    • 85203249229 scopus 로고    scopus 로고
    • Are gender differences in antidepressant response specific to serotoninergic agents? A comparative study of citalopram vs reboxetine
    • Berlanga C, Flores M. Are gender differences in antidepressant response specific to serotoninergic agents? A comparative study of citalopram vs reboxetine. International Journal of Neuropsychopharmacology 2004;7(Suppl 2):S167-8.
    • (2004) International Journal of Neuropsychopharmacology , vol.7 , pp. S167-S168
    • Berlanga, C.1    Flores, M.2
  • 9
    • 33846190717 scopus 로고    scopus 로고
    • Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine
    • Berlanga C, Flores-Ramos M. Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine. Journal of Affective Disorders 2006;95:119-23.
    • (2006) Journal of Affective Disorders , vol.95 , pp. 119-123
    • Berlanga, C.1    Flores-Ramos, M.2
  • 10
    • 77958142340 scopus 로고    scopus 로고
    • Reboxetine for acute treatment of major depression: Systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials
    • Eyding D, Lelgemann M, Grouven U, Harter M, Kromp M, Kaiser T. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010;341:4737.
    • (2010) BMJ , vol.341 , pp. 4737
    • Eyding, D.1    Lelgemann, M.2    Grouven, U.3    Harter, M.4    Kromp, M.5    Kaiser, T.6
  • 12
    • 0030879689 scopus 로고    scopus 로고
    • Citalopram and fluoxetine in major depression: Comparison of two clinical trials in a psychiatrist setting and in general practice (first trial)
    • Bougerol T, Scotto JC, Patris M, Strub N, Lemming O, Hopfner Petersen HE. Citalopram and fluoxetine in major depression: Comparison of two clinical trials in a psychiatrist setting and in general practice (first trial). Clinical Drug Investigation 1997;14(2):77-89.
    • (1997) Clinical Drug Investigation , vol.14 , Issue.2 , pp. 77-89
    • Bougerol, T.1    Scotto, J.C.2    Patris, M.3    Strub, N.4    Lemming, O.5    Hopfner Petersen, H.E.6
  • 13
    • 0030879689 scopus 로고    scopus 로고
    • Citalopram and fluoxetine in major depression: Comparison of two clinical trials in a psychiatrist setting and in general practice (second trial)
    • Bougerol T, Scotto J-C, Patris M, Strub N, Lemming O, Hopfner Petersen HE. Citalopram and fluoxetine in major depression: Comparison of two clinical trials in a psychiatrist setting and in general practice (second trial). Clinical Drug Investigation 1997;14(2):77-89.
    • (1997) Clinical Drug Investigation , vol.14 , Issue.2 , pp. 77-89
    • Bougerol, T.1    Scotto, J.-C.2    Patris, M.3    Strub, N.4    Lemming, O.5    Hopfner Petersen, H.E.6
  • 14
    • 8944259904 scopus 로고    scopus 로고
    • Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice
    • Patris M, Bouchard JM, Bougerol T, Charbonnier JF, Chevalier JF, Clerc G, et al. Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice. International Clinical Psychopharmacology 1996;11(2):129-36.
    • (1996) International Clinical Psychopharmacology , vol.11 , Issue.2 , pp. 129-136
    • Patris, M.1    Bouchard, J.M.2    Bougerol, T.3    Charbonnier, J.F.4    Chevalier, J.F.5    Clerc, G.6
  • 15
    • 0036236470 scopus 로고    scopus 로고
    • Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients
    • Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. Journal of Clinical Psychiatry 2002;63(4):331-6.
    • (2002) Journal of Clinical Psychiatry , vol.63 , Issue.4 , pp. 331-336
    • Burke, W.J.1    Gergel, I.2    Bose, A.3
  • 16
    • 0031881792 scopus 로고    scopus 로고
    • An open-label, controlled study of citalopram versus moclobemide in patients with major depression
    • Castanedo de Alba L, Meixueiro-Montes De Oca R. An open-label, controlled study of citalopram versus moclobemide in patients with major depression. Current Therapeutic Research 1998;59(2):107-15.
    • (1998) Current Therapeutic Research , vol.59 , Issue.2 , pp. 107-115
    • Castanedo de Alba, L.1    Meixueiro-Montes De Oca, R.2
  • 17
    • 27144516427 scopus 로고    scopus 로고
    • A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder
    • Colonna L, Andersen HF, Reines EH. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder. Current Medical Research and Opinion 2005;21(10):1659-68.
    • (2005) Current Medical Research and Opinion , vol.21 , Issue.10 , pp. 1659-1668
    • Colonna, L.1    Andersen, H.F.2    Reines, E.H.3
  • 19
    • 0031417460 scopus 로고    scopus 로고
    • A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general-practice
    • Ekselius L, von Knorring L, Eberhard G. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general-practice. International Clinical Psychopharmacology 1997;12(6):323-31.
    • (1997) International Clinical Psychopharmacology , vol.12 , Issue.6 , pp. 323-331
    • Ekselius, L.1    von Knorring, L.2    Eberhard, G.3
  • 20
    • 85203264465 scopus 로고    scopus 로고
    • Comparative, placebo-controlled study of the hypericum extract STW 3-VI with Citalopram in patients with moderate depression
    • Gastpar M, Bassler D, Zeller K. Comparative, placebo-controlled study of the hypericum extract STW 3-VI with Citalopram in patients with moderate depression. Medizinische Klinik 2005;100:117.
    • (2005) Medizinische Klinik , vol.100 , pp. 117
    • Gastpar, M.1    Bassler, D.2    Zeller, K.3
  • 21
    • 33645698267 scopus 로고    scopus 로고
    • Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: A double-blind, randomised, multicentre, placebo-controlled study
    • Gastpar M, Singer A, Zeller K. Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: A double-blind, randomised, multicentre, placebo-controlled study. Pharmacopsychiatry 2006;39(2):66-75.
    • (2006) Pharmacopsychiatry , vol.39 , Issue.2 , pp. 66-75
    • Gastpar, M.1    Singer, A.2    Zeller, K.3
  • 22
    • 79958105002 scopus 로고    scopus 로고
    • Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: A reanalysis of data from a controlled clinical trial
    • Singer A, Schmidt M, Hauke W, Stade K. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: A reanalysis of data from a controlled clinical trial. Phytomedicine 2011;18(8-9):739-42.
    • (2011) Phytomedicine , vol.18 , Issue.8-9 , pp. 739-742
    • Singer, A.1    Schmidt, M.2    Hauke, W.3    Stade, K.4
  • 24
    • 0030058987 scopus 로고    scopus 로고
    • Comparative study of three antidepressants: Preliminary results
    • Hosak L, Tuma I. Comparative study of three antidepressants: Preliminary results. Homeostasis in Health and Disease 1996;37(3):138-9.
    • (1996) Homeostasis in Health and Disease , vol.37 , Issue.3 , pp. 138-139
    • Hosak, L.1    Tuma, I.2
  • 25
    • 0032895998 scopus 로고    scopus 로고
    • [A comparative study of three antidepressants with a different mechanism of action in hospitalized patients]
    • Hosak L, Tuma I, Hanus H. [A comparative study of three antidepressants with a different mechanism of action in hospitalized patients]. Ceska a Slovenska Psychiatrie 1999;95(3):146-56.
    • (1999) Ceska a Slovenska Psychiatrie , vol.95 , Issue.3 , pp. 146-156
    • Hosak, L.1    Tuma, I.2    Hanus, H.3
  • 26
    • 0034569612 scopus 로고    scopus 로고
    • Costs and outcomes of use of amitriptyline, citalopram and fluoxetine in major depression: exploratory study
    • Hosak L, Tuma I, Hanus H, Straka L. Costs and outcomes of use of amitriptyline, citalopram and fluoxetine in major depression: exploratory study. Acta Medica (Hradec Kralove) 2000;43(4):133-7.
    • (2000) Acta Medica (Hradec Kralove) , vol.43 , Issue.4 , pp. 133-137
    • Hosak, L.1    Tuma, I.2    Hanus, H.3    Straka, L.4
  • 27
    • 80052440407 scopus 로고    scopus 로고
    • Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naive first-episode major depressive disorder in a Chinese population: A 6-week double-blind, randomized comparative study
    • Hsu J-W, Su T-P, Huang C-Y, Chen Y-S, Chou Y-H. Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naive first-episode major depressive disorder in a Chinese population: A 6-week double-blind, randomized comparative study. Journal of Clinical Psychopharmacology 2011;31(5):577-81.
    • (2011) Journal of Clinical Psychopharmacology , vol.31 , Issue.5 , pp. 577-581
    • Hsu, J.-W.1    Su, T.-P.2    Huang, C.-Y.3    Chen, Y.-S.4    Chou, Y.-H.5
  • 28
    • 0034021991 scopus 로고    scopus 로고
    • A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia
    • Karlsson I, Godderis J, Augusto De Mendonca Lima C, Nygaard H, Simanyi M, Taal M, et al. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia. International Journal of Geriatric Psychiatry 2000;15:295-305.
    • (2000) International Journal of Geriatric Psychiatry , vol.15 , pp. 295-305
    • Karlsson, I.1    Godderis, J.2    Augusto De Mendonca Lima, C.3    Nygaard, H.4    Simanyi, M.5    Taal, M.6
  • 29
    • 1642546276 scopus 로고    scopus 로고
    • Oxidative damage and major depression: The potential antioxidant action of selective serotonin-re-uptake inhibitors
    • Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: The potential antioxidant action of selective serotonin-re-uptake inhibitors. Redox Report 2003;8(6):365-70.
    • (2003) Redox Report , vol.8 , Issue.6 , pp. 365-370
    • Khanzode, S.D.1    Dakhale, G.N.2    Khanzode, S.S.3    Saoji, A.4    Palasodkar, R.5
  • 30
    • 0032416790 scopus 로고    scopus 로고
    • Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice
    • Kyle CJ, Petersen HE, Overo KF. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice. Depression and Anxiety 1998;8(4):147-53.
    • (1998) Depression and Anxiety , vol.8 , Issue.4 , pp. 147-153
    • Kyle, C.J.1    Petersen, H.E.2    Overo, K.F.3
  • 31
    • 27644565359 scopus 로고    scopus 로고
    • Escitalopram Versus Citalopram And Sertraline : A Double-Blind Controlled, Multi-Centric Trial In Indian Patients With Unipolar Major Depression
    • Lalit V, Appaya PM, Hegde RP, Mital AK, Mittal S, Nagpal R, et al. Escitalopram Versus Citalopram And Sertraline: A Double-Blind Controlled, Multi-Centric Trial In Indian Patients With Unipolar Major Depression. Indian Journal of Psychiatry 2004;46(4):333-41.
    • (2004) Indian Journal of Psychiatry , vol.46 , Issue.4 , pp. 333-341
    • Lalit, V.1    Appaya, P.M.2    Hegde, R.P.3    Mital, A.K.4    Mittal, S.5    Nagpal, R.6
  • 32
    • 77958142340 scopus 로고    scopus 로고
    • Reboxetine for acute treatment of major depression: Systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials
    • Eyding D, Lelgemann M, Grouven U, Harter M, Kromp M, Kaiser T. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010;341:4737.
    • (2010) BMJ , vol.341 , pp. 4737
    • Eyding, D.1    Lelgemann, M.2    Grouven, U.3    Harter, M.4    Kromp, M.5    Kaiser, T.6
  • 33
    • 33646691741 scopus 로고    scopus 로고
    • Efficacy and tolerability of reboxetine compared with citalopram: A double-blind study in patients with major depressive disorder
    • Langworth S, Bodlund O, Agren H. Efficacy and tolerability of reboxetine compared with citalopram: A double-blind study in patients with major depressive disorder. Journal of Clinical Psychopharmacology 2006;26(2):121-7.
    • (2006) Journal of Clinical Psychopharmacology , vol.26 , Issue.2 , pp. 121-127
    • Langworth, S.1    Bodlund, O.2    Agren, H.3
  • 34
    • 85203270778 scopus 로고    scopus 로고
    • Efficacy and tolerability of mirtazapine vs citalopram: a double-blind, randomized study in patients with major depressive disorder
    • Agren H, Leinonen E, Skarstein J, Behke K, Helsdingen JT. Efficacy and tolerability of mirtazapine vs citalopram: a double-blind, randomized study in patients with major depressive disorder. European Neuropsychopharmacology 1999;9(Suppl 5):228.
    • (1999) European Neuropsychopharmacology , vol.9 , pp. 228
    • Agren, H.1    Leinonen, E.2    Skarstein, J.3    Behke, K.4    Helsdingen, J.T.5
  • 36
    • 0032729491 scopus 로고    scopus 로고
    • Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder
    • Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. International Clinical Psychopharmacology 1999;14(6):329-37.
    • (1999) International Clinical Psychopharmacology , vol.14 , Issue.6 , pp. 329-337
    • Leinonen, E.1    Skarstein, J.2    Behnke, K.3    Agren, H.4    Helsdingen, J.T.5
  • 38
    • 85203296557 scopus 로고    scopus 로고
    • Mirtazapine has similar long-term efficacy and tolerability to citalopram and faster onset of action in the treatment of major depression
    • Leinonen E, Skarstein J, Behnke K, Angren H, Schutte AJ. Mirtazapine has similar long-term efficacy and tolerability to citalopram and faster onset of action in the treatment of major depression. European Neuropsychopharmacology 2000;10(Suppl 3):265.
    • (2000) European Neuropsychopharmacology , vol.10 , pp. 265
    • Leinonen, E.1    Skarstein, J.2    Behnke, K.3    Angren, H.4    Schutte, A.J.5
  • 39
    • 85203292292 scopus 로고    scopus 로고
    • Mirtazapine has similar long-term efficacy and tolerability to citalopram and faster onset of action in the treatment of major depression
    • Schutte AJ, Leinonen E, Skarstein J, Behnke K, Angren H. Mirtazapine has similar long-term efficacy and tolerability to citalopram and faster onset of action in the treatment of major depression. International Journal of Neuropsychopharmacology 2000;3(Suppl 1):193.
    • (2000) International Journal of Neuropsychopharmacology , vol.3 , pp. 193
    • Schutte, A.J.1    Leinonen, E.2    Skarstein, J.3    Behnke, K.4    Angren, H.5
  • 40
    • 0038441914 scopus 로고    scopus 로고
    • Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care
    • Lepola U M, Loft H, Reines E H. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. International Clinical Psychopharmacology 2003;18(4):211-7.
    • (2003) International Clinical Psychopharmacology , vol.18 , Issue.4 , pp. 211-217
    • Lepola, U.M.1    Loft, H.2    Reines, E.H.3
  • 41
    • 2342481128 scopus 로고    scopus 로고
    • Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder
    • Lepola U, Wade A, Andersen HF. Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder. International Clinical Psychopharmacology 2004;19(3):149-55.
    • (2004) International Clinical Psychopharmacology , vol.19 , Issue.3 , pp. 149-155
    • Lepola, U.1    Wade, A.2    Andersen, H.F.3
  • 43
    • 0001632725 scopus 로고    scopus 로고
    • Escitalopram is efficacious and well tolerated in the treatment of depression in primary care
    • Reines EH, Loft H, Lepola U. Escitalopram is efficacious and well tolerated in the treatment of depression in primary care. European Neuropsychopharmacology 2002;12(Suppl 3):S254.
    • (2002) European Neuropsychopharmacology , vol.12 , pp. S254
    • Reines, E.H.1    Loft, H.2    Lepola, U.3
  • 44
    • 79957439084 scopus 로고    scopus 로고
    • Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial
    • Lewis G, Mulligan J, Wiles N, Cowen P, Craddock N, Ikeda M, et al. Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial. British Journal of Psychiatry 2011;198:464-71.
    • (2011) British Journal of Psychiatry , vol.198 , pp. 464-471
    • Lewis, G.1    Mulligan, J.2    Wiles, N.3    Cowen, P.4    Craddock, N.5    Ikeda, M.6
  • 45
    • 45549098108 scopus 로고    scopus 로고
    • GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol
    • Thomas L, Mulligan J, Mason V, Tallon D, Wiles N, Cowen P, et al. GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol. Trials 2008;22(9):29.
    • (2008) Trials , vol.22 , Issue.9 , pp. 29
    • Thomas, L.1    Mulligan, J.2    Mason, V.3    Tallon, D.4    Wiles, N.5    Cowen, P.6
  • 48
    • 35348961423 scopus 로고    scopus 로고
    • Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison
    • Matreja PS, Badyal DK, Khosla P, Deswal RS. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison. Human Psychopharmacology 2007;22(7):477-82.
    • (2007) Human Psychopharmacology , vol.22 , Issue.7 , pp. 477-482
    • Matreja, P.S.1    Badyal, D.K.2    Khosla, P.3    Deswal, R.S.4
  • 50
    • 67649884744 scopus 로고    scopus 로고
    • The self-reported Montgomery-Asberg depression rating scale is a useful evaluative tool in major depressive disorder
    • Fantino B, Moore N. The self-reported Montgomery-Asberg depression rating scale is a useful evaluative tool in major depressive disorder. BMC Psychiatry 2009;9:26.
    • (2009) BMC Psychiatry , vol.9 , pp. 26
    • Fantino, B.1    Moore, N.2
  • 51
    • 17644423099 scopus 로고    scopus 로고
    • Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder
    • Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. International Clinical Psychopharmacology 2005;20(20):131-7.
    • (2005) International Clinical Psychopharmacology , vol.20 , Issue.20 , pp. 131-137
    • Moore, N.1    Verdoux, H.2    Fantino, B.3
  • 52
    • 0035012684 scopus 로고    scopus 로고
    • Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study
    • Navarro V, Gasto C, Torres X, Marcos T, Pintor L. Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study. Acta Psychiatrica Scandinavica 2001;103(6):435-40.
    • (2001) Acta Psychiatrica Scandinavica , vol.103 , Issue.6 , pp. 435-440
    • Navarro, V.1    Gasto, C.2    Torres, X.3    Marcos, T.4    Pintor, L.5
  • 53
    • 79952484668 scopus 로고    scopus 로고
    • Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study
    • Ou JJ, Xun GL, Wu RR, Li LH, Fang MS, Zhang HG, et al. Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study. Psychopharmacology (Berl) 2011;213:639-46.
    • (2011) Psychopharmacology (Berl) , vol.213 , pp. 639-646
    • Ou, J.J.1    Xun, G.L.2    Wu, R.R.3    Li, L.H.4    Fang, M.S.5    Zhang, H.G.6
  • 54
    • 8944224539 scopus 로고    scopus 로고
    • Screening and treating depressed patients A comparison of two controlled citalopram trials across treatment settings: hospitalized patients vs patients treated by their family doctors
    • Fuglum E, Rosenberg C, Damsbo N, Stage K, Lauritzen L, Bech P. Screening and treating depressed patients A comparison of two controlled citalopram trials across treatment settings: hospitalized patients vs patients treated by their family doctors. Acta Psychiatrica Scandinavica 1996;94(1):18-25.
    • (1996) Acta Psychiatrica Scandinavica , vol.94 , Issue.1 , pp. 18-25
    • Fuglum, E.1    Rosenberg, C.2    Damsbo, N.3    Stage, K.4    Lauritzen, L.5    Bech, P.6
  • 55
    • 0028267563 scopus 로고
    • Citalopram and imipramine in the treatment of depressive patients in general-practice. A Nordic multicentre clinical study
    • Rosenberg C, Damsbo N, Fuglum E, Jacobsen LV, Horsgard S. Citalopram and imipramine in the treatment of depressive patients in general-practice. A Nordic multicentre clinical study. International Clinical Psychopharmacology 1994;9(Suppl 1):41-8.
    • (1994) International Clinical Psychopharmacology , vol.9 , pp. 41-48
    • Rosenberg, C.1    Damsbo, N.2    Fuglum, E.3    Jacobsen, L.V.4    Horsgard, S.5
  • 56
    • 85203280808 scopus 로고    scopus 로고
    • Flexible-dose comparison of the safety and efficacy of Lu 26-054 (escitalopram), citalopram, and placebo in the treatment of major depressive disorder
    • Forest Laboratories. Flexible-dose comparison of the safety and efficacy of Lu 26-054 (escitalopram), citalopram, and placebo in the treatment of major depressive disorder. www.forestclinicaltrials.com.
    • www.forestclinicaltrials.com
    • Forest, L.1
  • 58
    • 78651292672 scopus 로고    scopus 로고
    • Targeting remission by 8 weeks: When should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor?
    • Cooper-Kazaz R, Rigbi A, Lerer B. Targeting remission by 8 weeks: When should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor?. Comprehensive Psychiatry 2011;52(1):9-16.
    • (2011) Comprehensive Psychiatry , vol.52 , Issue.1 , pp. 9-16
    • Cooper-Kazaz, R.1    Rigbi, A.2    Lerer, B.3
  • 60
    • 0034333287 scopus 로고    scopus 로고
    • Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline
    • Stahl SM. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Biological Psychiatry 2000;48:894-901.
    • (2000) Biological Psychiatry , vol.48 , pp. 894-901
    • Stahl, S.M.1
  • 61
    • 85203265512 scopus 로고    scopus 로고
    • Citalopram vs. sertraline vs. placebo in the treatment of major depression
    • Stahl SM, Wilcox C, Overo K. Citalopram vs. sertraline vs. placebo in the treatment of major depression. European Neuropsychopharmacology 1999;9(Suppl 5):232.
    • (1999) European Neuropsychopharmacology , vol.9 , pp. 232
    • Stahl, S.M.1    Wilcox, C.2    Overo, K.3
  • 62
    • 10244254025 scopus 로고    scopus 로고
    • Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study The lucifer group
    • Haffmans PM, Timmerman L, Hoogduin CA. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study The lucifer group. International Clinical Psychopharmacology 1996;11(3):157-64.
    • (1996) International Clinical Psychopharmacology , vol.11 , Issue.3 , pp. 157-164
    • Haffmans, P.M.1    Timmerman, L.2    Hoogduin, C.A.3
  • 64
    • 37349069949 scopus 로고    scopus 로고
    • Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients
    • Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Clinical Therapeutics 2007;29(11):2319-32.
    • (2007) Clinical Therapeutics , vol.29 , Issue.11 , pp. 2319-2332
    • Yevtushenko, V.Y.1    Belous, A.I.2    Yevtushenko, Y.G.3    Gusinin, S.E.4    Buzik, O.J.5    Agibalova, T.V.6
  • 66
    • 54049120666 scopus 로고    scopus 로고
    • Short-term intravenous citalopram augmentation in partial/nonresponders with major depression: a randomized placebo-controlled study
    • Altamura AC, Dell'Osso B, Buoli M, Bosi M, Mundo E. Short-term intravenous citalopram augmentation in partial/nonresponders with major depression: a randomized placebo-controlled study. International Clinical Psychopharmacology 2008;23:198-202.
    • (2008) International Clinical Psychopharmacology , vol.23 , pp. 198-202
    • Altamura, A.C.1    Dell'Osso, B.2    Buoli, M.3    Bosi, M.4    Mundo, E.5
  • 67
    • 54449101151 scopus 로고    scopus 로고
    • Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study
    • Altamura AC, Dell'Osso B, Buoli M, Zanoni S, Mundo E. Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology 2008;28:406-10.
    • (2008) Journal of Clinical Psychopharmacology , vol.28 , pp. 406-410
    • Altamura, A.C.1    Dell'Osso, B.2    Buoli, M.3    Zanoni, S.4    Mundo, E.5
  • 68
    • 42749090717 scopus 로고    scopus 로고
    • Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
    • Amiaz R, Fostick L, Gershon A, Zohar J. Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study. European Neuropsychopharmacology 2008;18(6):455-61.
    • (2008) European Neuropsychopharmacology , vol.18 , Issue.6 , pp. 455-461
    • Amiaz, R.1    Fostick, L.2    Gershon, A.3    Zohar, J.4
  • 69
    • 34147190820 scopus 로고    scopus 로고
    • Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus
    • Amsterdam JD, Shults J, Rutherford N, Schwartz S. Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus. Neuropsychobiology 2006;54:208-14.
    • (2006) Neuropsychobiology , vol.54 , pp. 208-214
    • Amsterdam, J.D.1    Shults, J.2    Rutherford, N.3    Schwartz, S.4
  • 73
    • 36248977101 scopus 로고    scopus 로고
    • Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF)
    • Angermann CE, Gelbrich G, Stork S, Fallgatter A, Deckert J, Faller H, et al. Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). European Journal of Heart Failure 2007;9(12):1212-22.
    • (2007) European Journal of Heart Failure , vol.9 , Issue.12 , pp. 1212-1222
    • Angermann, C.E.1    Gelbrich, G.2    Stork, S.3    Fallgatter, A.4    Deckert, J.5    Faller, H.6
  • 75
    • 80055035073 scopus 로고    scopus 로고
    • Therapy of moderately severe depressions in daily practice: first patient care research study reinforces clinical data
    • Anonymous. Therapy of moderately severe depressions in daily practice: first patient care research study reinforces clinical data. MMW Fortschritte der Medizin 2011;153(41):38-9.
    • (2011) MMW Fortschritte Der Medizin , vol.153 , Issue.41 , pp. 38-39
  • 76
    • 2442581073 scopus 로고    scopus 로고
    • Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder
    • Azorin JM, Llorca PM, Despiegel N, Verpillat P. Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder. Encephale 2004;30(2):158-66.
    • (2004) Encephale , vol.30 , Issue.2 , pp. 158-166
    • Azorin, J.M.1    Llorca, P.M.2    Despiegel, N.3    Verpillat, P.4
  • 77
    • 33645243454 scopus 로고    scopus 로고
    • Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine
    • Baldwin D, Bridgman K, Buis C. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine. Journal of Psychopharmacology 2006;20(1):91-6.
    • (2006) Journal of Psychopharmacology , vol.20 , Issue.1 , pp. 91-96
    • Baldwin, D.1    Bridgman, K.2    Buis, C.3
  • 78
    • 79251479076 scopus 로고    scopus 로고
    • Treatment of depressive symptoms in Parkinson's disease
    • Barone P. Treatment of depressive symptoms in Parkinson's disease. European Journal of Neurology 2011;18:11-5.
    • (2011) European Journal of Neurology , vol.18 , pp. 11-15
    • Barone, P.1
  • 79
    • 78149318681 scopus 로고    scopus 로고
    • A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder
    • Bauer M, El-Khalili N, Datto C, Szamosi J, Eriksson H. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder. Journal of Affective Disorders 2010;127:19-30.
    • (2010) Journal of Affective Disorders , vol.127 , pp. 19-30
    • Bauer, M.1    El-Khalili, N.2    Datto, C.3    Szamosi, J.4    Eriksson, H.5
  • 82
    • 0023105775 scopus 로고
    • Dexamethasone suppression test and the response to antidepressant depending on their central monoaminergic action in major depression
    • Benkelfat C, Poirier MF, Leouffre P, Gay C, Loo H. Dexamethasone suppression test and the response to antidepressant depending on their central monoaminergic action in major depression. Canadian Journal of Psychiatry 1987;32:175-8.
    • (1987) Canadian Journal of Psychiatry , vol.32 , pp. 175-178
    • Benkelfat, C.1    Poirier, M.F.2    Leouffre, P.3    Gay, C.4    Loo, H.5
  • 83
    • 38349090764 scopus 로고    scopus 로고
    • An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[(11)C]methyl-l-tryptophan PET study
    • Berney A, Nishikawa M, Benkelfat C, Debonnel G, Gobbi G, Diksic M. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[(11)C]methyl-l-tryptophan PET study. Neurochemistry International 2008;52(4-5):701-8.
    • (2008) Neurochemistry International , vol.52 , Issue.4-5 , pp. 701-708
    • Berney, A.1    Nishikawa, M.2    Benkelfat, C.3    Debonnel, G.4    Gobbi, G.5    Diksic, M.6
  • 84
    • 0031415135 scopus 로고    scopus 로고
    • Clinical variables and response to citalopram in Major Depression: An open multicentric study
    • Bersani G, Saito A, Pallanti S, Sasso E, Tosca P. Clinical variables and response to citalopram in Major Depression: An open multicentric study. Rivista Di Psichiatria 1997;32(6):260-7.
    • (1997) Rivista Di Psichiatria , vol.32 , Issue.6 , pp. 260-267
    • Bersani, G.1    Saito, A.2    Pallanti, S.3    Sasso, E.4    Tosca, P.5
  • 85
    • 0021956185 scopus 로고
    • The effects of citalopram (Lu 10-171) on the serotonin (5-HT) uptake kinetics in platelets from endogenously depressed patients
    • Beving H, Bjerkenstedt L, Malmgren R, Olsson P, Unge G. The effects of citalopram (Lu 10-171) on the serotonin (5-HT) uptake kinetics in platelets from endogenously depressed patients. Journal of Neural Transmission 1985;61(1-2):95-104.
    • (1985) Journal of Neural Transmission , vol.61 , Issue.1-2 , pp. 95-104
    • Beving, H.1    Bjerkenstedt, L.2    Malmgren, R.3    Olsson, P.4    Unge, G.5
  • 86
    • 1442337925 scopus 로고    scopus 로고
    • Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression
    • Bhagwagar Z, Cowen PJ, Goodwin GM, Harmer CJ. Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. American Journal of Psychiatry 2004;161(1):166-8.
    • (2004) American Journal of Psychiatry , vol.161 , Issue.1 , pp. 166-168
    • Bhagwagar, Z.1    Cowen, P.J.2    Goodwin, G.M.3    Harmer, C.J.4
  • 88
    • 9644303563 scopus 로고    scopus 로고
    • Escitalopram (Cipralex and Lexapro) for the treatment of depression
    • Bijl D. Escitalopram (Cipralex and Lexapro) for the treatment of depression. Geneesmiddelenbulletin 2004;38(12):89-90.
    • (2004) Geneesmiddelenbulletin , vol.38 , Issue.12 , pp. 89-90
    • Bijl, D.1
  • 89
    • 84880505690 scopus 로고
    • Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor- a dose-response study in depressed patients
    • Bjerkenstedt L, Edman G, Flyckt L, Hagenfeldt L, Sedvall G, Wiesel FA. Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor- a dose-response study in depressed patients. Psychopharmacology 1985;87(3):253-9.
    • (1985) Psychopharmacology , vol.87 , Issue.3 , pp. 253-259
    • Bjerkenstedt, L.1    Edman, G.2    Flyckt, L.3    Hagenfeldt, L.4    Sedvall, G.5    Wiesel, F.A.6
  • 90
    • 33845459246 scopus 로고    scopus 로고
    • The sequenced treatment alternatives to relieve depression (STAR*D): A first look at the initial pharmacotherapy results
    • Blier P. The sequenced treatment alternatives to relieve depression (STAR*D): A first look at the initial pharmacotherapy results. Clinical Neuropsychiatry 2006;3(4):265-7.
    • (2006) Clinical Neuropsychiatry , vol.3 , Issue.4 , pp. 265-267
    • Blier, P.1
  • 91
    • 0030781186 scopus 로고    scopus 로고
    • Citalopram and viloxazine in the treatment of depression by means of slow drop infusion. A double-blind comparative trial
    • Bouchard JM, Strub N, Nil R. Citalopram and viloxazine in the treatment of depression by means of slow drop infusion. A double-blind comparative trial. Journal of Affective Disorders 1997;46:51-8.
    • (1997) Journal of Affective Disorders , vol.46 , pp. 51-58
    • Bouchard, J.M.1    Strub, N.2    Nil, R.3
  • 92
    • 76949091626 scopus 로고    scopus 로고
    • Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine
    • Boulenger JP, Hermes A, Huusom AK, Weiller E. Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine. Current Medical Research and Opinion 2010;26:605-14.
    • (2010) Current Medical Research and Opinion , vol.26 , pp. 605-614
    • Boulenger, J.P.1    Hermes, A.2    Huusom, A.K.3    Weiller, E.4
  • 93
    • 85203289707 scopus 로고    scopus 로고
    • Citalopram versus imipramine in the treatment of inpatient depression - results from a double-blind, placebo-controlled trial
    • 30th May 4th June 1998
    • Bowden CL. Citalopram versus imipramine in the treatment of inpatient depression - results from a double-blind, placebo-controlled trial. 151st Annual Meeting of the American Psychiatric Association. Toronto, Ontario, Canada. 30th May 4th June 1998.
    • 151st Annual Meeting of the American Psychiatric Association. Toronto, Ontario, Canada
    • Bowden, C.L.1
  • 94
    • 85203292885 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of citalopram in outpatient adults with asthma and major depressive disorder
    • Brown ES, Khan DA, Vigil L, Rush AA. A randomized, double-blind, placebo-controlled trial of citalopram in outpatient adults with asthma and major depressive disorder. Neuropsychopharmacology 2004;29:S92.
    • (2004) Neuropsychopharmacology , vol.29 , pp. S92
    • Brown, E.S.1    Khan, D.A.2    Vigil, L.3    Rush, A.A.4
  • 95
    • 85203293692 scopus 로고    scopus 로고
    • The association of diabetes mellitus with response to depression treatment
    • Bryan C. The association of diabetes mellitus with response to depression treatment. Dissertation Abstracts International 2007;68(3-B):1588.
    • (2007) Dissertation Abstracts International , vol.68 , Issue.3-B , pp. 1588
    • Bryan, C.1
  • 96
    • 42649127734 scopus 로고    scopus 로고
    • Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression
    • Bun'kova KM. Efficacy and tolerability of clomipramine, pirlindole and escitalopram in the treatment of neurotic level depression. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 2008;108:29-32.
    • (2008) Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova , vol.108 , pp. 29-32
    • Bun'kova, K.M.1
  • 97
    • 85203248871 scopus 로고    scopus 로고
    • Double-blind parallel comparison of citalopram, imipramine and placebo in patients with major depression or bipolar disorder, depressed
    • Carman JS. Double-blind parallel comparison of citalopram, imipramine and placebo in patients with major depression or bipolar disorder, depressed. Unpublished 2002.
    • (2002) Unpublished
    • Carman, J.S.1
  • 98
    • 85203268316 scopus 로고    scopus 로고
    • Double-blind comparison of citalopram versus amitriptyline in the treatment of depressive illness in Great Britain
    • Chakravarti SK. Double-blind comparison of citalopram versus amitriptyline in the treatment of depressive illness in Great Britain. Unpublished/ LUNDBECK 2002.
    • (2002) Unpublished/ LUNDBECK
    • Chakravarti, S.K.1
  • 99
    • 85203284753 scopus 로고    scopus 로고
    • A randomized controlled trial of citalopram in major depression following mild traumatic brain injury
    • Chan F, Lanctacutet KL, Herrmann N, Kiss A, McCullagh S, Feinstein A, et al. A randomized controlled trial of citalopram in major depression following mild traumatic brain injury. World Psychiatry 2009;8:184.
    • (2009) World Psychiatry , vol.8 , pp. 184
    • Chan, F.1    Lanctacutet, K.L.2    Herrmann, N.3    Kiss, A.4    McCullagh, S.5    Feinstein, A.6
  • 100
    • 27644462768 scopus 로고    scopus 로고
    • Changes of neurotransmitter in patients with post-stroke depression observed with encephalofluctuography technology
    • Chen KN, Chen SL, Luo F, Tan YY. Changes of neurotransmitter in patients with post-stroke depression observed with encephalofluctuography technology. Chinese Journal of Clinical Rehabilitation 2005;9(16):118-9.
    • (2005) Chinese Journal of Clinical Rehabilitation , vol.9 , Issue.16 , pp. 118-119
    • Chen, K.N.1    Chen, S.L.2    Luo, F.3    Tan, Y.Y.4
  • 102
    • 78651292672 scopus 로고    scopus 로고
    • Targeting remission by 8 weeks: When should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor?
    • Cooper-Kazaz R, Rigbi A, Lerer B. Targeting remission by 8 weeks: When should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor?. Comprehensive Psychiatry 2011;52:9-16.
    • (2011) Comprehensive Psychiatry , vol.52 , pp. 9-16
    • Cooper-Kazaz, R.1    Rigbi, A.2    Lerer, B.3
  • 103
    • 77958520435 scopus 로고    scopus 로고
    • Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: A pilot study
    • Court A, Mulder C, Kerr M, Yuen HP, Boasman M, Goldstone S. Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people: A pilot study. Journal of Psychiatric Research 2010;44:1027-34.
    • (2010) Journal of Psychiatric Research , vol.44 , pp. 1027-1034
    • Court, A.1    Mulder, C.2    Kerr, M.3    Yuen, H.P.4    Boasman, M.5    Goldstone, S.6
  • 105
    • 78651338227 scopus 로고    scopus 로고
    • The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and non remission in the suicide assessment methodology study
    • Daly EJ, Trivedi MH, Fava M, Shelton R, Wisniewski SR, Morris DW, et al. The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and non remission in the suicide assessment methodology study. Journal of Clinical Psychopharmacology 2011;31(1):31-8.
    • (2011) Journal of Clinical Psychopharmacology , vol.31 , Issue.1 , pp. 31-38
    • Daly, E.J.1    Trivedi, M.H.2    Fava, M.3    Shelton, R.4    Wisniewski, S.R.5    Morris, D.W.6
  • 107
    • 78649913813 scopus 로고    scopus 로고
    • Using non-steroidal anti-inflammatory drugs in the treatment of depression
    • Davis A, Gilhooley M, Agius M. Using non-steroidal anti-inflammatory drugs in the treatment of depression. Psychiatria Danubina 2010;22:S49-S52.
    • (2010) Psychiatria Danubina , vol.22 , pp. S49-S52
    • Davis, A.1    Gilhooley, M.2    Agius, M.3
  • 108
    • 77649187826 scopus 로고    scopus 로고
    • Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes
    • Davis LL, Wisniewski SR, Howland RH, Trivedi MH, Husain MM, Fava M. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes. Drug Alcohol Dependence 2010;107:161-70.
    • (2010) Drug Alcohol Dependence , vol.107 , pp. 161-170
    • Davis, L.L.1    Wisniewski, S.R.2    Howland, R.H.3    Trivedi, M.H.4    Husain, M.M.5    Fava, M.6
  • 109
    • 85203299606 scopus 로고    scopus 로고
    • A double-blind, controlled phase III of citalopram versus placebo in the treatment of depressive illness
    • Deakin JFW. A double-blind, controlled phase III of citalopram versus placebo in the treatment of depressive illness. Unpublished 2002.
    • (2002) Unpublished
    • Deakin, J.F.W.1
  • 112
    • 42249110197 scopus 로고    scopus 로고
    • Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase
    • Dell'Osso B, Hadley S, Allen A, Baker B, Chaplin WF, Hollander E. Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. The Journal of Clinical Psychiatry 2008;69:452-6.
    • (2008) The Journal of Clinical Psychiatry , vol.69 , pp. 452-456
    • Dell'Osso, B.1    Hadley, S.2    Allen, A.3    Baker, B.4    Chaplin, W.F.5    Hollander, E.6
  • 113
    • 85203245241 scopus 로고    scopus 로고
    • A control study of citalopram combined with quetiapine in the treatment of female depression
    • Deng W, Xu C, Ma T. A control study of citalopram combined with quetiapine in the treatment of female depression. Journal of Clinical Psychosomatic Diseases 2006;12(4):274-9.
    • (2006) Journal of Clinical Psychosomatic Diseases , vol.12 , Issue.4 , pp. 274-279
    • Deng, W.1    Xu, C.2    Ma, T.3
  • 114
    • 33846382787 scopus 로고    scopus 로고
    • Augmentation strategies in STAR*D: A review
    • Denko TC, Friedman ES. Augmentation strategies in STAR*D: A review. Primary Psychiatry 2007;14(1):46-50.
    • (2007) Primary Psychiatry , vol.14 , Issue.1 , pp. 46-50
    • Denko, T.C.1    Friedman, E.S.2
  • 115
    • 48649084162 scopus 로고    scopus 로고
    • Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study
    • Devos D, Dujardin K, Poirot I, Moreau C, Cottencin O, Thomas P. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Movement Disorders 2008;23:850-7.
    • (2008) Movement Disorders , vol.23 , pp. 850-857
    • Devos, D.1    Dujardin, K.2    Poirot, I.3    Moreau, C.4    Cottencin, O.5    Thomas, P.6
  • 116
    • 85203296570 scopus 로고    scopus 로고
    • Clomipramine and quetiapine augmentation for obsessive compulsive disorder compared to sustained fluoxetine treatment
    • Diniz JB, Pereira CAB, Miguel EC, Shavitt RG. Clomipramine and quetiapine augmentation for obsessive compulsive disorder compared to sustained fluoxetine treatment. European Neuropsychopharmacology 2010;20:S547-S548.
    • (2010) European Neuropsychopharmacology , vol.20 , pp. S547-S548
    • Diniz, J.B.1    Pereira, C.A.B.2    Miguel, E.C.3    Shavitt, R.G.4
  • 117
    • 85203265982 scopus 로고    scopus 로고
    • Antidepressant treatment modulates neural responses to self-referential words in subjects with high neuroticism
    • Di Simplicio M, Norbury R, Harmer CJ. Antidepressant treatment modulates neural responses to self-referential words in subjects with high neuroticism. European Neuropsychopharmacology 2010;20:S172.
    • (2010) European Neuropsychopharmacology , vol.20 , pp. S172
    • Di Simplicio, M.1    Norbury, R.2    Harmer, C.J.3
  • 118
    • 33746850501 scopus 로고    scopus 로고
    • After the failure of citalopram for depression, what next?
    • Doggrell SA. After the failure of citalopram for depression, what next?. Expert Opinion on Pharmacotherapy 2006;7(11):1515-8.
    • (2006) Expert Opinion on Pharmacotherapy , vol.7 , Issue.11 , pp. 1515-1518
    • Doggrell, S.A.1
  • 119
    • 34247869696 scopus 로고    scopus 로고
    • Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease
    • Dornelas EA, Burg MM. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease. JAMA 2007;297(17):1879-80.
    • (2007) JAMA , vol.297 , Issue.17 , pp. 1879-1880
    • Dornelas, E.A.1    Burg, M.M.2
  • 123
    • 84870879493 scopus 로고    scopus 로고
    • The potential of the nicotinic channel blocker tc-5214 as augmentation treatment in patients with major depression
    • Dunbar G, Hosford D. The potential of the nicotinic channel blocker tc-5214 as augmentation treatment in patients with major depression. European Neuropsychopharmacology 2010;20:S334.
    • (2010) European Neuropsychopharmacology , vol.20 , pp. S334
    • Dunbar, G.1    Hosford, D.2
  • 125
    • 77958142340 scopus 로고    scopus 로고
    • Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials
    • Eyding D, Lelgemann M, Grouven U, Härter M, Kromp M, Kaiser T, et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010;341:c4737.
    • (2010) BMJ , vol.341 , pp. c4737
    • Eyding, D.1    Lelgemann, M.2    Grouven, U.3    Härter, M.4    Kromp, M.5    Kaiser, T.6
  • 126
    • 85047695030 scopus 로고    scopus 로고
    • A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report
    • Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, et al. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. American Journal of Psychiatry 2006;163(7):1161-72.
    • (2006) American Journal of Psychiatry , vol.163 , Issue.7 , pp. 1161-1172
    • Fava, M.1    Rush, A.J.2    Wisniewski, S.R.3    Nierenberg, A.A.4    Alpert, J.E.5    McGrath, P.J.6
  • 129
    • 0033254613 scopus 로고    scopus 로고
    • Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression
    • Feighner JP, Overo K. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. Journal of Clinical Psychiatry 1999;60(12):824-30.
    • (1999) Journal of Clinical Psychiatry , vol.60 , Issue.12 , pp. 824-830
    • Feighner, J.P.1    Overo, K.2
  • 130
    • 16244418668 scopus 로고    scopus 로고
    • Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder
    • Fernandez JL, Montgomery S, Francois C. Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder. Pharmacoeconomics 2005;23(2):155-67.
    • (2005) Pharmacoeconomics , vol.23 , Issue.2 , pp. 155-167
    • Fernandez, J.L.1    Montgomery, S.2    Francois, C.3
  • 131
    • 84869288102 scopus 로고    scopus 로고
    • Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study
    • Fernandez M. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study. Revista de Neurologia 2009;48:S23.
    • (2009) Revista de Neurologia , vol.48 , pp. S23
    • Fernandez, M.1
  • 133
    • 76949090568 scopus 로고    scopus 로고
    • The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life
    • Ford AH, Flicker L, McCaul K, Van Bockxmeer F, Hegarty S, Hirani V. The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life. Trials 2010;11:8.
    • (2010) Trials , vol.11 , pp. 8
    • Ford, A.H.1    Flicker, L.2    McCaul, K.3    Van Bockxmeer, F.4    Hegarty, S.5    Hirani, V.6
  • 134
    • 67349243030 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: The relevance of the placebo effect and psychological symptoms
    • Fraguas R, da Silva Telles RM, Alves TCTF, Andrei AM, Rays J, Iosifescu DV. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: The relevance of the placebo effect and psychological symptoms. Contemporary Clinical Trials 2009;30:205-11.
    • (2009) Contemporary Clinical Trials , vol.30 , pp. 205-211
    • Fraguas, R.1    da Silva Telles, R.M.2    Alves, T.C.T.F.3    Andrei, A.M.4    Rays, J.5    Iosifescu, D.V.6
  • 135
    • 2342422080 scopus 로고    scopus 로고
    • Clinical response augments NK cell activity independent of treatment modality: A randomized double-blind placebo controlled antidepressant trial
    • Frank MG, Hendricks SE, Burke WJ, Johnson DR. Clinical response augments NK cell activity independent of treatment modality: A randomized double-blind placebo controlled antidepressant trial. Psychological Medicine 2004;34(3):491-8.
    • (2004) Psychological Medicine , vol.34 , Issue.3 , pp. 491-498
    • Frank, M.G.1    Hendricks, S.E.2    Burke, W.J.3    Johnson, D.R.4
  • 137
    • 47749102168 scopus 로고    scopus 로고
    • Adults with both anxiety and depression respond poorly to treatment
    • Gilbert G. Adults with both anxiety and depression respond poorly to treatment. Journal of the National Medical Association 2008;100:870-1.
    • (2008) Journal of the National Medical Association , vol.100 , pp. 870-871
    • Gilbert, G.1
  • 140
    • 81255149448 scopus 로고    scopus 로고
    • Sleep and cognition at baseline and the effects of REM sleep diminution after 1week of antidepressive treatment in patients with depression
    • Goder R, Seeck-Hirschner M, Stingele K, Huchzermeier C, Kropp C, Palaschewski M, et al. Sleep and cognition at baseline and the effects of REM sleep diminution after 1week of antidepressive treatment in patients with depression. Journal of Sleep Research 2011;20(4):544-51.
    • (2011) Journal of Sleep Research , vol.20 , Issue.4 , pp. 544-551
    • Goder, R.1    Seeck-Hirschner, M.2    Stingele, K.3    Huchzermeier, C.4    Kropp, C.5    Palaschewski, M.6
  • 145
    • 0034009783 scopus 로고    scopus 로고
    • Efficacy of intravenous citalopram compared with oral citalopram for severe depression. Safety and efficacy data from a double-blind, double-dummy trial
    • Guelfi JD, Strub N, Loft H. Efficacy of intravenous citalopram compared with oral citalopram for severe depression. Safety and efficacy data from a double-blind, double-dummy trial. Journal of Affective Disorders 2000;58(3):201-9.
    • (2000) Journal of Affective Disorders , vol.58 , Issue.3 , pp. 201-209
    • Guelfi, J.D.1    Strub, N.2    Loft, H.3
  • 147
    • 85203280989 scopus 로고    scopus 로고
    • A controlled clinical comparison of citalopram and placebo in depressed patients
    • Harrington RN. A controlled clinical comparison of citalopram and placebo in depressed patients. Unpublished 2002.
    • (2002) Unpublished
    • Harrington, R.N.1
  • 148
    • 14544273732 scopus 로고    scopus 로고
    • Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression
    • Hegerl U, Mergl R, Henkel V, Pogarell O, Muller-Siecheneder F, Frodl T, et al. Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression. Psychopharmacology 2006;178(1):58-66.
    • (2006) Psychopharmacology , vol.178 , Issue.1 , pp. 58-66
    • Hegerl, U.1    Mergl, R.2    Henkel, V.3    Pogarell, O.4    Muller-Siecheneder, F.5    Frodl, T.6
  • 150
    • 2442666729 scopus 로고    scopus 로고
    • Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression
    • Hemels MEH, Kasper S, Walter E, Einarson TR. Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression. Annals of Pharmacotherapy  2004;38(6):954-60.
    • (2004) Annals of Pharmacotherapy , vol.38 , Issue.6 , pp. 954-960
    • Hemels, M.E.H.1    Kasper, S.2    Walter, E.3    Einarson, T.R.4
  • 151
    • 67349138171 scopus 로고    scopus 로고
    • Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder
    • Herrera-Guzman I, Gudayol-Ferre E, Herrera-Guzman D, Guardia-Olmos J, Hinojosa-Calvo E, Herrera-Abarca JE. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. Journal of Psychiatric Research 2009;43:855-63.
    • (2009) Journal of Psychiatric Research , vol.43 , pp. 855-863
    • Herrera-Guzman, I.1    Gudayol-Ferre, E.2    Herrera-Guzman, D.3    Guardia-Olmos, J.4    Hinojosa-Calvo, E.5    Herrera-Abarca, J.E.6
  • 153
    • 0033764960 scopus 로고    scopus 로고
    • Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance
    • Hindmarch I, Kimber S, Cockle SM. Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance. International Clinical Psychopharmacology 2000;15(6):305-18.
    • (2000) International Clinical Psychopharmacology , vol.15 , Issue.6 , pp. 305-318
    • Hindmarch, I.1    Kimber, S.2    Cockle, S.M.3
  • 155
    • 46749152570 scopus 로고    scopus 로고
    • A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression
    • Holtzheimer PE III, Meeks TW, Kelley ME, Mufti M, Young R, McWhorter K. A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression. International Journal of Geriatric Psychiatry 2008;23:625-31.
    • (2008) International Journal of Geriatric Psychiatry , vol.23 , pp. 625-631
    • Holtzheimer, P.E.1    Meeks, T.W.2    Kelley, M.E.3    Mufti, M.4    Young, R.5    McWhorter, K.6
  • 158
    • 85203260553 scopus 로고    scopus 로고
    • A controlled, clinical comparison of citalopram and imipramine in depressed patients
    • Johnson DA. A controlled, clinical comparison of citalopram and imipramine in depressed patients. Unpublished 2002.
    • (2002) Unpublished
    • Johnson, D.A.1
  • 159
    • 0009710586 scopus 로고    scopus 로고
    • Clinical consequences of non-compliance with antidepressant therapy: A comparison of fluoxetine and citalopram
    • Judge R, Parry M, Quail D, Campbell A, Koke S. Clinical consequences of non-compliance with antidepressant therapy: A comparison of fluoxetine and citalopram. International Journal of Neuropsychopharmacology 2000;3(1):211.
    • (2000) International Journal of Neuropsychopharmacology , vol.3 , Issue.1 , pp. 211
    • Judge, R.1    Parry, M.2    Quail, D.3    Campbell, A.4    Koke, S.5
  • 161
  • 163
    • 33645780692 scopus 로고    scopus 로고
    • The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: A randomized trial
    • Ketter TA, Greist JH, Graham JA, Roberts JN, Thompson TR, Nanry KP. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: A randomized trial. Journal of Clinical Psychiatry 2006;67:400-6.
    • (2006) Journal of Clinical Psychiatry , vol.67 , pp. 400-406
    • Ketter, T.A.1    Greist, J.H.2    Graham, J.A.3    Roberts, J.N.4    Thompson, T.R.5    Nanry, K.P.6
  • 166
    • 78149283788 scopus 로고    scopus 로고
    • Home-delivered problem adaptation therapy (PATH) for depressed, cognitively impaired, disabled elders: A preliminary study
    • Kiosses DN, Arean PA, Teri L, Alexopoulos GS. Home-delivered problem adaptation therapy (PATH) for depressed, cognitively impaired, disabled elders: A preliminary study. American Journal of Geriatric Psychiatry 2010;18:988-98.
    • (2010) American Journal of Geriatric Psychiatry , vol.18 , pp. 988-998
    • Kiosses, D.N.1    Arean, P.A.2    Teri, L.3    Alexopoulos, G.S.4
  • 168
    • 33845609634 scopus 로고    scopus 로고
    • Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial
    • Kornstein SG, Bose A, Li D, Saikali KG, Gandhi C. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial. Journal of Clinical Psychiatry 2006;67(11):1767-75.
    • (2006) Journal of Clinical Psychiatry , vol.67 , Issue.11 , pp. 1767-1775
    • Kornstein, S.G.1    Bose, A.2    Li, D.3    Saikali, K.G.4    Gandhi, C.5
  • 169
    • 85203295705 scopus 로고    scopus 로고
    • Citalopram infusion therapy of uni- and bipolar depression
    • Copenhagen, Denmark. 20 24th September 1998
    • Kovacs G, Kelemen. Citalopram infusion therapy of uni- and bipolar depression. 9th Congress of the Association of European Psychiatrists. Copenhagen, Denmark. 20 24th September 1998. 1998.
    • (1998) 9Th Congress of the Association of European Psychiatrists
    • Kelemen, K.G.1
  • 170
    • 41149140327 scopus 로고    scopus 로고
    • Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study
    • Kraus MR, Schäfer A, Schöttker K, Keicher C, Weissbrich B, Hofbauer I. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut 2008;57:531-6.
    • (2008) Gut , vol.57 , pp. 531-536
    • Kraus, M.R.1    Schäfer, A.2    Schöttker, K.3    Keicher, C.4    Weissbrich, B.5    Hofbauer, I.6
  • 171
    • 67349100997 scopus 로고    scopus 로고
    • The Indiana Cancer Pain and Depression (INCPAD) trial. Design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants
    • Kroenke K, Theobald D, Norton K, Sanders R, Schlundt S, McCalley S. The Indiana Cancer Pain and Depression (INCPAD) trial. Design of a telecare management intervention for cancer-related symptoms and baseline characteristics of study participants. General Hospital Psychiatry 2009;31:240-53.
    • (2009) General Hospital Psychiatry , vol.31 , pp. 240-253
    • Kroenke, K.1    Theobald, D.2    Norton, K.3    Sanders, R.4    Schlundt, S.5    McCalley, S.6
  • 172
    • 0346787772 scopus 로고    scopus 로고
    • Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants
    • Kühn KU, Quednow BB, Thiel M, Falkai P, Maier W, Elger CE. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy & Behavior 2003;4(6):674-9.
    • (2003) Epilepsy & Behavior , vol.4 , Issue.6 , pp. 674-679
    • Kühn, K.U.1    Quednow, B.B.2    Thiel, M.3    Falkai, P.4    Maier, W.5    Elger, C.E.6
  • 174
    • 44249107313 scopus 로고    scopus 로고
    • Antidepressant use in nonmajor depression: Secondary analysis of a program to encourage active, rewarding lives for seniors (PEARLS), a randomized controlled trial in older adults from 2000 to 2003
    • Lakey SL, Gray SL, Ciechanowsk P, Schwartz S, LoGerfo J. Antidepressant use in nonmajor depression: Secondary analysis of a program to encourage active, rewarding lives for seniors (PEARLS), a randomized controlled trial in older adults from 2000 to 2003. American Journal Geriatric Pharmacotherapy 2008;6(1):12-20.
    • (2008) American Journal Geriatric Pharmacotherapy , vol.6 , Issue.1 , pp. 12-20
    • Lakey, S.L.1    Gray, S.L.2    Ciechanowsk, P.3    Schwartz, S.4    LoGerfo, J.5
  • 175
    • 54049133688 scopus 로고    scopus 로고
    • Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials
    • Lam RW, Andersen HF, Wade AG. Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials. International Clinical Psychopharmacology 2008;23:181-7.
    • (2008) International Clinical Psychopharmacology , vol.23 , pp. 181-187
    • Lam, R.W.1    Andersen, H.F.2    Wade, A.G.3
  • 176
    • 75149152945 scopus 로고    scopus 로고
    • Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram
    • Lavretsky H, Siddarth P, Irwin MR. Improving depression and enhancing resilience in family dementia caregivers: a pilot randomized placebo-controlled trial of escitalopram. American Journal of Geriatric Psychiatry 2010;18:154-62.
    • (2010) American Journal of Geriatric Psychiatry , vol.18 , pp. 154-162
    • Lavretsky, H.1    Siddarth, P.2    Irwin, M.R.3
  • 177
    • 69649101602 scopus 로고    scopus 로고
    • Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study
    • Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Research 2009;169:124-31.
    • (2009) Psychiatry Research , vol.169 , pp. 124-131
    • Leuchter, A.F.1    Cook, I.A.2    Marangell, L.B.3    Gilmer, W.S.4    Burgoyne, K.S.5    Howland, R.H.6
  • 178
    • 77955910341 scopus 로고    scopus 로고
    • (S)-(+)-mecamylamine (TC-5214): A neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for major depressive disorder (MDD)
    • Lindsley CW. (S)-(+)-mecamylamine (TC-5214): A neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for major depressive disorder (MDD). ACS Chemical Neuroscience 2010;1:530-1.
    • (2010) ACS Chemical Neuroscience , vol.1 , pp. 530-531
    • Lindsley, C.W.1
  • 179
    • 0029665324 scopus 로고    scopus 로고
    • Citalopram and desmethylcitalopram for psychiatric patients
    • Linnet K, Olesen OV. Citalopram and desmethylcitalopram for psychiatric patients. Ugeskrift for Laeger 1996;158(35):4920-3.
    • (1996) Ugeskrift for Laeger , vol.158 , Issue.35 , pp. 4920-4923
    • Linnet, K.1    Olesen, O.V.2
  • 180
    • 84876287447 scopus 로고    scopus 로고
    • Effect of citalopram treatment on post-stroke depression and neurological functional rehabilitation
    • Liu Y, Xu R. Effect of citalopram treatment on post-stroke depression and neurological functional rehabilitation. Chinese Journal of Rehabilitation 2006;21:174-5.
    • (2006) Chinese Journal of Rehabilitation , vol.21 , pp. 174-175
    • Liu, Y.1    Xu, R.2
  • 181
    • 85041817325 scopus 로고    scopus 로고
    • Clinical control study of citalopram and amitriptyline in the treatment of post-stroke depression
    • Liu G, Liu R, Wang Y, He G. Clinical control study of citalopram and amitriptyline in the treatment of post-stroke depression. Journal of Clinical Psychological Medicine 2006;16:153-4.
    • (2006) Journal of Clinical Psychological Medicine , vol.16 , pp. 153-154
    • Liu, G.1    Liu, R.2    Wang, Y.3    He, G.4
  • 182
    • 85203298417 scopus 로고    scopus 로고
    • Efficacy of nimodipine combined with citalopram in treatment of 68 patients with vascular depression
    • Li WQ, Chen ZH, Li DX. Efficacy of nimodipine combined with citalopram in treatment of 68 patients with vascular depression. Chinese Journal of New Drugs and Clinical Remedies 2006;25(7):504-7.
    • (2006) Chinese Journal of New Drugs and Clinical Remedies , vol.25 , Issue.7 , pp. 504-507
    • Li, W.Q.1    Chen, Z.H.2    Li, D.X.3
  • 184
    • 85203256331 scopus 로고    scopus 로고
    • Randomized placebo-controlled trial of citalopram demonstrating depression prevention during treatment for HN cancer
    • Lydiatt WM, Denman D, Burke WJ. Randomized placebo-controlled trial of citalopram demonstrating depression prevention during treatment for HN cancer. Archives of Otolaryngology - Head and Neck Surgery 2006;132:845.
    • (2006) Archives of Otolaryngology - Head and Neck Surgery , vol.132 , pp. 845
    • Lydiatt, W.M.1    Denman, D.2    Burke, W.J.3
  • 185
    • 77952368632 scopus 로고    scopus 로고
    • TNF-alpha antagonist infliximab in the treatment of depression in older adults: Results of a prematurely ended, randomized, placebo-controlled trial
    • Maas DW, Westendorp RGJ, Willems JM, De Craen AJM, Van der Mast RC. TNF-alpha antagonist infliximab in the treatment of depression in older adults: Results of a prematurely ended, randomized, placebo-controlled trial. Journal of Clinical Psychopharmacology 2010;30(3):343-5.
    • (2010) Journal of Clinical Psychopharmacology , vol.30 , Issue.3 , pp. 343-345
    • Maas, D.W.1    Westendorp, R.G.J.2    Willems, J.M.3    De Craen, A.J.M.4    Van der Mast, R.C.5
  • 187
    • 85121368303 scopus 로고    scopus 로고
    • Comparison of treatment to influence depression as a risk factor for Ischemic Heart Disease with new generation antidepressants
    • Malik NA. Comparison of treatment to influence depression as a risk factor for Ischemic Heart Disease with new generation antidepressants. XII World Congress of Psychiatry, Aug 24-9, 2002, Yokohama, Japan. 2002.
    • (2002) XII World Congress of Psychiatry, Aug 24-9, 2002, Yokohama, Japan
    • Malik, N.A.1
  • 188
    • 77951246605 scopus 로고    scopus 로고
    • Radio electric treatment vs. Es-Citalopram in the treatment of panic disorders associated with major depression: an open-label, naturalistic study
    • Mannu P, Rinaldi S, Fontani V, Castagna A, Margotti ML. Radio electric treatment vs. Es-Citalopram in the treatment of panic disorders associated with major depression: an open-label, naturalistic study. Acupuncture & Electro-Therapeutics Research 2009;34:135-49.
    • (2009) Acupuncture & Electro-Therapeutics Research , vol.34 , pp. 135-149
    • Mannu, P.1    Rinaldi, S.2    Fontani, V.3    Castagna, A.4    Margotti, M.L.5
  • 189
    • 83055180710 scopus 로고    scopus 로고
    • A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode
    • Martinez JM, Katon W, Greist JH, Kroenke K, Thase ME, Meyers AL, et al. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode. International Clinical Psychopharmacology 2012;27(1):17-26.
    • (2012) International Clinical Psychopharmacology , vol.27 , Issue.1 , pp. 17-26
    • Martinez, J.M.1    Katon, W.2    Greist, J.H.3    Kroenke, K.4    Thase, M.E.5    Meyers, A.L.6
  • 190
    • 34347403696 scopus 로고    scopus 로고
    • Antidepressants versus psychotherapy: Successful treatment in patients with coronary heart disease
    • Martini B. Antidepressants versus psychotherapy: Successful treatment in patients with coronary heart disease. Deutsche Apotheker Zeitung 2007;147(19):50-2.
    • (2007) Deutsche Apotheker Zeitung , vol.147 , Issue.19 , pp. 50-52
    • Martini, B.1
  • 191
    • 1242314700 scopus 로고    scopus 로고
    • Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study
    • Martiny K, Lunde M, Simonsen C, Clemmensen L, Poulsen DL, Solstad K, et al. Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study. Acta Psychiatrica Scandinavica 2004;109(3):230-4.
    • (2004) Acta Psychiatrica Scandinavica , vol.109 , Issue.3 , pp. 230-234
    • Martiny, K.1    Lunde, M.2    Simonsen, C.3    Clemmensen, L.4    Poulsen, D.L.5    Solstad, K.6
  • 193
    • 75949117878 scopus 로고    scopus 로고
    • Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment
    • McCabe C, Mishor Z, Cowen PJ, Harmer CJ. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biological Psychiatry 2010;67(5):439-45.
    • (2010) Biological Psychiatry , vol.67 , Issue.5 , pp. 439-445
    • McCabe, C.1    Mishor, Z.2    Cowen, P.J.3    Harmer, C.J.4
  • 194
    • 60349112465 scopus 로고    scopus 로고
    • Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report
    • McGrath PJ, Khan AY, Trivedi MH, Stewart JW, Morris DW, Wisniewski SR. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. Journal of Clinical Psychiatry 2008;69:1847-55.
    • (2008) Journal of Clinical Psychiatry , vol.69 , pp. 1847-1855
    • McGrath, P.J.1    Khan, A.Y.2    Trivedi, M.H.3    Stewart, J.W.4    Morris, D.W.5    Wisniewski, S.R.6
  • 196
    • 0035157572 scopus 로고    scopus 로고
    • Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a DASB PET imaging study
    • Meyer JH, Wilson AA, Ginovart N, Goulding V, Hussey D, Hood K, et al. Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a DASB PET imaging study. American Journal of Psychiatry 2001;58(12):1839-49.
    • (2001) American Journal of Psychiatry , vol.58 , Issue.12 , pp. 1839-1849
    • Meyer, J.H.1    Wilson, A.A.2    Ginovart, N.3    Goulding, V.4    Hussey, D.5    Hood, K.6
  • 197
    • 4944230732 scopus 로고    scopus 로고
    • Related factors of post-stroke depression and therapeutical effect of citalopram
    • Miao S-Y, Shi Y-J. Related factors of post-stroke depression and therapeutical effect of citalopram. Chinese Journal of Clinical Rehabilitation 2004;8(19):3718-9.
    • (2004) Chinese Journal of Clinical Rehabilitation , vol.8 , Issue.19 , pp. 3718-3719
    • Miao, S.-Y.1    Shi, Y.-J.2
  • 198
    • 75149165962 scopus 로고    scopus 로고
    • Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients
    • Minelli A, Bortolomasi M, Scassellati C, Salvoro B, Avesani M, Manganotti P. Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients. Brain Stimulation 2010;3:15-21.
    • (2010) Brain Stimulation , vol.3 , pp. 15-21
    • Minelli, A.1    Bortolomasi, M.2    Scassellati, C.3    Salvoro, B.4    Avesani, M.5    Manganotti, P.6
  • 199
    • 70350342499 scopus 로고    scopus 로고
    • Effects of erythropoietin on emotional processing biases in patients with major depression: An exploratory fMRI study
    • Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ. Effects of erythropoietin on emotional processing biases in patients with major depression: An exploratory fMRI study. Psychopharmacology 2009;207:133-42.
    • (2009) Psychopharmacology , vol.207 , pp. 133-142
    • Miskowiak, K.W.1    Favaron, E.2    Hafizi, S.3    Inkster, B.4    Goodwin, G.M.5    Cowen, P.J.6
  • 201
    • 77957328857 scopus 로고    scopus 로고
    • Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: A double-blind, placebo-controlled trial
    • Morasco BJ, Loftis JM, Indest DW, Ruimy S, Davison JW, Felker B. Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: A double-blind, placebo-controlled trial. Psychosomatics 2010;51:401-8.
    • (2010) Psychosomatics , vol.51 , pp. 401-408
    • Morasco, B.J.1    Loftis, J.M.2    Indest, D.W.3    Ruimy, S.4    Davison, J.W.5    Felker, B.6
  • 203
    • 54349088773 scopus 로고    scopus 로고
    • Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication
    • Muhonen LH, Lahti J, Sinclair D, Lönnqvist J, Alho H. Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication. Substance abuse treatment, prevention, and policy 2008;3:20.
    • (2008) Substance abuse treatment, prevention, and policy , vol.3 , pp. 20
    • Muhonen, L.H.1    Lahti, J.2    Sinclair, D.3    Lönnqvist, J.4    Alho, H.5
  • 204
    • 64649088504 scopus 로고    scopus 로고
    • Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence
    • Muhonen LH, Lonnqvist J, Lahti J, Alho H. Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence. Psychiatry Research 2009;167:115-22.
    • (2009) Psychiatry Research , vol.167 , pp. 115-122
    • Muhonen, L.H.1    Lonnqvist, J.2    Lahti, J.3    Alho, H.4
  • 205
    • 42249095073 scopus 로고    scopus 로고
    • Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence
    • Muhonen LH, Lonnqvist J, Juva K, Alho H. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. Journal of Clinical Psychiatry 2008;69(3):392-9.
    • (2008) Journal of Clinical Psychiatry , vol.69 , Issue.3 , pp. 392-399
    • Muhonen, L.H.1    Lonnqvist, J.2    Juva, K.3    Alho, H.4
  • 208
    • 1642503034 scopus 로고    scopus 로고
    • Effect of zinc supplementation on antidepressant therapy in unipolar depression: A preliminary placebo-controlled study
    • Nowak G, Siwek M, Dudek D, Zieba A, Pilc A. Effect of zinc supplementation on antidepressant therapy in unipolar depression: A preliminary placebo-controlled study. Polish Journal of Pharmacology 2003;55(6):1143-7.
    • (2003) Polish Journal of Pharmacology , vol.55 , Issue.6 , pp. 1143-1147
    • Nowak, G.1    Siwek, M.2    Dudek, D.3    Zieba, A.4    Pilc, A.5
  • 210
    • 47849090005 scopus 로고    scopus 로고
    • Sildenafil treatment of women with antidepressant-associated sexual dysfunction: A randomized controlled trial
    • Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: A randomized controlled trial. JAMA 2008;300:395-404.
    • (2008) JAMA , vol.300 , pp. 395-404
    • Nurnberg, H.G.1    Hensley, P.L.2    Heiman, J.R.3    Croft, H.A.4    Debattista, C.5    Paine, S.6
  • 211
    • 0025244327 scopus 로고
    • The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study
    • Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study. British Journal of Psychiatry 1990;157:894-901.
    • (1990) British Journal of Psychiatry , vol.157 , pp. 894-901
    • Nyth, A.L.1    Gottfries, C.G.2
  • 212
    • 0034041102 scopus 로고    scopus 로고
    • Safe treatment of depression with mirtazapine
    • Oberpichler-Schwenk HO. Safe treatment of depression with mirtazapine. Psychopharmakotherapie 2000;7(5):1-4.
    • (2000) Psychopharmakotherapie , vol.7 , Issue.5 , pp. 1-4
    • Oberpichler-Schwenk, H.O.1
  • 213
    • 78951471427 scopus 로고    scopus 로고
    • Aripiprazole as adjunctive therapy for patients with major depressive disorder: Overview and implications of clinical trial data
    • Pae CU, Forbes A, Patkar AA. Aripiprazole as adjunctive therapy for patients with major depressive disorder: Overview and implications of clinical trial data. CNS Drugs 2011;25:109-27.
    • (2011) CNS Drugs , vol.25 , pp. 109-127
    • Pae, C.U.1    Forbes, A.2    Patkar, A.A.3
  • 214
    • 78751532134 scopus 로고    scopus 로고
    • A preliminary randomised double-blind placebo controlled study of the effects of citalopram (Celexa) on depression, anxiety and quality of life in patients with severe COPD
    • Palmer SM, Clary GL, Babyak MA, Wilkerson N, Silvertooth E, Hellegars C, et al. A preliminary randomised double-blind placebo controlled study of the effects of citalopram (Celexa) on depression, anxiety and quality of life in patients with severe COPD. Chest 2002;122(4):144.
    • (2002) Chest , vol.122 , Issue.4 , pp. 144
    • Palmer, S.M.1    Clary, G.L.2    Babyak, M.A.3    Wilkerson, N.4    Silvertooth, E.5    Hellegars, C.6
  • 217
    • 63449087185 scopus 로고    scopus 로고
    • Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder
    • Perlis RH, Fijal B, Adams DH, Sutton VK, Trivedi MH, Houston JP. Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder. Biological Psychiatry 2009;65:785-91.
    • (2009) Biological Psychiatry , vol.65 , pp. 785-791
    • Perlis, R.H.1    Fijal, B.2    Adams, D.H.3    Sutton, V.K.4    Trivedi, M.H.5    Houston, J.P.6
  • 219
    • 16644395855 scopus 로고    scopus 로고
    • Clinical efficacy of citalopram in patients with hypertension and concomitant depression
    • Pogosova GV, Gudkova OA, Iufereva IuM, Tikhomirova EA. Clinical efficacy of citalopram in patients with hypertension and concomitant depression. Kardiologiia 2004;44(10):49-53.
    • (2004) Kardiologiia , vol.44 , Issue.10 , pp. 49-53
    • Pogosova, G.V.1    Gudkova, O.A.2    Iufereva, I.3    Tikhomirova, E.A.4
  • 220
    • 79952759919 scopus 로고    scopus 로고
    • Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression
    • Portella MJ, de Diego-Adeliño J, Ballesteros J, Puigdemont D, Oller S, Santos B. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. Journal of Clinical Psychiatry 2010 [ePub ahead of print].
    • (2010) Journal of Clinical Psychiatry
    • Portella, M.J.1    de Diego-Adeliño, J.2    Ballesteros, J.3    Puigdemont, D.4    Oller, S.5    Santos, B.6
  • 221
    • 0348143048 scopus 로고    scopus 로고
    • Cognitive-behavioral Therapy and Pharmacotherapy in the Treatment of Patients Suffering with Unipolar Recurrent Depression
    • Prasko J, Johanovska E, Klar I, Pec O, Ondrackova I, Sipek J, et al. Cognitive-behavioral Therapy and Pharmacotherapy in the Treatment of Patients Suffering with Unipolar Recurrent Depression. Ceska a Slovenska Psychiatrie 2003;99(2):103-5.
    • (2003) Ceska a Slovenska Psychiatrie , vol.99 , Issue.2 , pp. 103-105
    • Prasko, J.1    Johanovska, E.2    Klar, I.3    Pec, O.4    Ondrackova, I.5    Sipek, J.6
  • 222
    • 77749339852 scopus 로고    scopus 로고
    • Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: A randomized placebo-controlled pilot study
    • Quante A, Zeugmann S, Luborzewski A, Schommer N, Langosch J, Born C. Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: A randomized placebo-controlled pilot study. Human Psychopharmacology 2010;25:126-32.
    • (2010) Human Psychopharmacology , vol.25 , pp. 126-132
    • Quante, A.1    Zeugmann, S.2    Luborzewski, A.3    Schommer, N.4    Langosch, J.5    Born, C.6
  • 223
    • 33947630716 scopus 로고    scopus 로고
    • Combination of citalopram and nortriptyline in the treatment of severe major depression: A double-blind, placebo-controlled trial
    • Raisi F, Habibi N, Nasehi AA, Akhondzadeh S. Combination of citalopram and nortriptyline in the treatment of severe major depression: A double-blind, placebo-controlled trial. Therapy 2007;4(2):187-92.
    • (2007) Therapy , vol.4 , Issue.2 , pp. 187-192
    • Raisi, F.1    Habibi, N.2    Nasehi, A.A.3    Akhondzadeh, S.4
  • 224
    • 4544324119 scopus 로고    scopus 로고
    • Prediction of the response to citalopram and reboxetine in post-stroke depressed patients: The reasons of the enrollment of patients without cognitive impairment
    • Rampello L, Alvano A. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients: The reasons of the enrollment of patients without cognitive impairment. Psychopharmacology 2004;175:264.
    • (2004) Psychopharmacology , vol.175 , pp. 264
    • Rampello, L.1    Alvano, A.2
  • 225
    • 8344281496 scopus 로고    scopus 로고
    • Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache
    • Rampello L, Alvano A, Chiechio S, Malaguarnera M, Raffaele R, Vecchio I, et al. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology 2004;50(4):322-8.
    • (2004) Neuropsychobiology , vol.50 , Issue.4 , pp. 322-328
    • Rampello, L.1    Alvano, A.2    Chiechio, S.3    Malaguarnera, M.4    Raffaele, R.5    Vecchio, I.6
  • 226
    • 2342510868 scopus 로고    scopus 로고
    • Prediction of the response to citalopram and reboxetine in post-stroke depressed patients
    • Rampello L, Chiechio S, Nicoletti G, Alvano A, Vecchio I, Raffaele R, et al. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology 2004;173(1-2):73-8.
    • (2004) Psychopharmacology , vol.173 , Issue.1-2 , pp. 73-78
    • Rampello, L.1    Chiechio, S.2    Nicoletti, G.3    Alvano, A.4    Vecchio, I.5    Raffaele, R.6
  • 228
    • 77957835860 scopus 로고    scopus 로고
    • A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury
    • Rapoport MJ, Mitchell RA, McCullagh S, Herrmann N, Chan F, Kiss A, et al. A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury. Journal of Clinical Psychiatry 2010;71(9):1125-30.
    • (2010) Journal of Clinical Psychiatry , vol.71 , Issue.9 , pp. 1125-1130
    • Rapoport, M.J.1    Mitchell, R.A.2    McCullagh, S.3    Herrmann, N.4    Chan, F.5    Kiss, A.6
  • 230
  • 232
    • 84930316194 scopus 로고
    • Citalopram in the treatment of depression in specialist practice. Morning versus evening administration
    • Rasmussen S, Bech P. Citalopram in the treatment of depression in specialist practice. Morning versus evening administration. Clinical Neuropharmacology 1992;15(1):529.
    • (1992) Clinical Neuropharmacology , vol.15 , Issue.1 , pp. 529
    • Rasmussen, S.1    Bech, P.2
  • 233
    • 33847054797 scopus 로고    scopus 로고
    • Treatment and treatments: Evaluation of therapeutic efficacy of integrated pharmacologic and psychotherapeutic treatment in outpatients with major depression
    • Riva M, Lurati C, Durbano F, Regispani F, Mencacci C. Treatment and treatments: Evaluation of therapeutic efficacy of integrated pharmacologic and psychotherapeutic treatment in outpatients with major depression. Italian Journal of Psychopathology 2006;12(3):323-31.
    • (2006) Italian Journal of Psychopathology , vol.12 , Issue.3 , pp. 323-331
    • Riva, M.1    Lurati, C.2    Durbano, F.3    Regispani, F.4    Mencacci, C.5
  • 235
    • 68449092600 scopus 로고    scopus 로고
    • Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression
    • Robinson RG, Tenev V, Jorge RE. Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression. American Journal of Geriatric Psychiatry 2009;17:682-7.
    • (2009) American Journal of Geriatric Psychiatry , vol.17 , pp. 682-687
    • Robinson, R.G.1    Tenev, V.2    Jorge, R.E.3
  • 236
    • 16444386614 scopus 로고    scopus 로고
    • Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial
    • Rocca P, Calvarese P, Faggiano F, Marchiaro L, Mathis F, Rivoira E, et al. Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial. Journal of Clinical Psychiatry 2005;66(3):360-9.
    • (2005) Journal of Clinical Psychiatry , vol.66 , Issue.3 , pp. 360-369
    • Rocca, P.1    Calvarese, P.2    Faggiano, F.3    Marchiaro, L.4    Mathis, F.5    Rivoira, E.6
  • 239
    • 48949088845 scopus 로고    scopus 로고
    • Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features
    • Rush AJ, Wisniewski SR, Warden D, Luther JF, Davis LL, Fava M. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Archives of General Psychiatry 2008;65:870-80.
    • (2008) Archives of General Psychiatry , vol.65 , pp. 870-880
    • Rush, A.J.1    Wisniewski, S.R.2    Warden, D.3    Luther, J.F.4    Davis, L.L.5    Fava, M.6
  • 240
    • 0037111498 scopus 로고    scopus 로고
    • Mri subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression
    • Salloway S, Correia S, Boyle P, Malloy P, Schneider L, Lavretsky H, et al. Mri subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression. Journal of the Neurological Sciences 2002;203-204:227-33.
    • (2002) Journal of the Neurological Sciences , vol.203-204 , pp. 227-233
    • Salloway, S.1    Correia, S.2    Boyle, P.3    Malloy, P.4    Schneider, L.5    Lavretsky, H.6
  • 241
    • 77749243262 scopus 로고    scopus 로고
    • Es-Citalopram for the prevention of PEG-IFN-alpha and ribavirin associated depression in HCV-infected patients without psychiatric risk factors
    • Schaefer M. Es-Citalopram for the prevention of PEG-IFN-alpha and ribavirin associated depression in HCV-infected patients without psychiatric risk factors. Hepatology 2008;48:432A-433A.
    • (2008) Hepatology , vol.48 , pp. 432A-433A
    • Schaefer, M.1
  • 242
    • 71149101597 scopus 로고    scopus 로고
    • Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression
    • Schfer A, Scheurlen M, Seufert J, Keicher C, Weissbrich B, Rieger P. Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression. Journal of Hepatology 2010;52:10-5.
    • (2010) Journal of Hepatology , vol.52 , pp. 10-15
    • Schfer, A.1    Scheurlen, M.2    Seufert, J.3    Keicher, C.4    Weissbrich, B.5    Rieger, P.6
  • 243
    • 34147126925 scopus 로고    scopus 로고
    • Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder
    • Schmitt L, Tonnoir B, Arbus C. Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder. Neuropsychobiology 2006;54(4):201-7.
    • (2006) Neuropsychobiology , vol.54 , Issue.4 , pp. 201-207
    • Schmitt, L.1    Tonnoir, B.2    Arbus, C.3
  • 244
    • 78649946380 scopus 로고    scopus 로고
    • Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression
    • Segal ZV, Bieling P, Young T, MacQueen G, Cooke R, Martin L. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Archives of General Psychiatry 2010;67:1256-64.
    • (2010) Archives of General Psychiatry , vol.67 , pp. 1256-1264
    • Segal, Z.V.1    Bieling, P.2    Young, T.3    Macqueen, G.4    Cooke, R.5    Martin, L.6
  • 245
    • 77950958736 scopus 로고    scopus 로고
    • A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood
    • Serfaty MA, Osborne D, Buszewicz MJ, Blizard R, Raven PW. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood. International Clinical Psychopharmacology 2010;25:132-42.
    • (2010) International Clinical Psychopharmacology , vol.25 , pp. 132-142
    • Serfaty, M.A.1    Osborne, D.2    Buszewicz, M.J.3    Blizard, R.4    Raven, P.W.5
  • 246
    • 77958468458 scopus 로고    scopus 로고
    • A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: The RESPOND trial
    • Sharp DJ, Chew-Graham CA, Tylee A, Lewis G, Howard L, Anderson I. A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: The RESPOND trial. Health Technology Assessment 2010;14:1-181.
    • (2010) Health Technology Assessment , vol.14 , pp. 1-181
    • Sharp, D.J.1    Chew-Graham, C.A.2    Tylee, A.3    Lewis, G.4    Howard, L.5    Anderson, I.6
  • 250
    • 33745599729 scopus 로고    scopus 로고
    • Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life
    • Soares CN, Arsenio H, Joffe H, Bankier B, Cassano P, Petrillo LF, et al. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause 2006;13(5):780-6.
    • (2006) Menopause , vol.13 , Issue.5 , pp. 780-786
    • Soares, C.N.1    Arsenio, H.2    Joffe, H.3    Bankier, B.4    Cassano, P.5    Petrillo, L.F.6
  • 251
    • 77954952690 scopus 로고    scopus 로고
    • Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder
    • Soares CN, Thase ME, Clayton A, Guico Pabia CJ, Focht K, Jiang Q. Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder. Menopause 2010;17:700-11.
    • (2010) Menopause , vol.17 , pp. 700-711
    • Soares, C.N.1    Thase, M.E.2    Clayton, A.3    Guico Pabia, C.J.4    Focht, K.5    Jiang, Q.6
  • 252
    • 79960779425 scopus 로고    scopus 로고
    • Citalopram versus desipramine in treatment resistant depression: Effect of continuation or switching strategies. A randomized open study
    • Souery D, Serretti A, Calati R, Oswald P, Massat I, Konstantinidis A, et al. Citalopram versus desipramine in treatment resistant depression: Effect of continuation or switching strategies. A randomized open study. World Journal of Biological Psychiatry 2011;12(5):364-75.
    • (2011) World Journal of Biological Psychiatry , vol.12 , Issue.5 , pp. 364-375
    • Souery, D.1    Serretti, A.2    Calati, R.3    Oswald, P.4    Massat, I.5    Konstantinidis, A.6
  • 255
    • 24944558006 scopus 로고    scopus 로고
    • Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users
    • Stein MD, Solomon DA, Anderson BJ, Herman DS, Anthony JL, Brown RA, et al. Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users. American Journal on Addictions 2005;14(4):346-57.
    • (2005) American Journal on Addictions , vol.14 , Issue.4 , pp. 346-357
    • Stein, M.D.1    Solomon, D.A.2    Anderson, B.J.3    Herman, D.S.4    Anthony, J.L.5    Brown, R.A.6
  • 256
    • 85076888333 scopus 로고    scopus 로고
    • Comparative study of citalopram combined with buspirone for treatment of refractory depression
    • Sun Q, Zen D, Luo S. Comparative study of citalopram combined with buspirone for treatment of refractory depression. Journal of Clinical Psychological Medicine 2004;14(4):221-2.
    • (2004) Journal of Clinical Psychological Medicine , vol.14 , Issue.4 , pp. 221-222
    • Sun, Q.1    Zen, D.2    Luo, S.3
  • 259
    • 85203263721 scopus 로고    scopus 로고
    • A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group, Flexible Dose Titration, Add-On Study of TC-5214 in the Treatment of MDD With Subjects Who Are Partial Responders or Non-Responders to Citalopram Therapy
    • Targacept Inc. A Multi-Center, Double Blind, Randomized, Placebo-Controlled, Parallel Group, Flexible Dose Titration, Add-On Study of TC-5214 in the Treatment of MDD With Subjects Who Are Partial Responders or Non-Responders to Citalopram Therapy. www.clinicaltrials.gov 2008.
    • (2008) www.clinicaltrials.gov
    • Targacept, I.1
  • 260
    • 77953693729 scopus 로고    scopus 로고
    • Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression
    • Thase ME, Nierenberg AA, Vrijland P, Van Oers HJ, Schutte AJ, Simmons JH. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression. International Clinical Psychopharmacology 2010;25:189-98.
    • (2010) International Clinical Psychopharmacology , vol.25 , pp. 189-198
    • Thase, M.E.1    Nierenberg, A.A.2    Vrijland, P.3    Van Oers, H.J.4    Schutte, A.J.5    Simmons, J.H.6
  • 261
    • 79952809764 scopus 로고    scopus 로고
    • Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: A randomized, open-label study
    • Thase ME, Ninan PT, Musgnung JJ, Trivedi MH. Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: A randomized, open-label study. Primary Care Companion to the Journal of Clinical Psychiatry 2011;13(1):0m00979.
    • (2011) Primary Care Companion to the Journal of Clinical Psychiatry , vol.13 , Issue.1 , pp. 0m00979
    • Thase, M.E.1    Ninan, P.T.2    Musgnung, J.J.3    Trivedi, M.H.4
  • 264
    • 0027132516 scopus 로고
    • Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram
    • Van Bemmel AL, Van den Hoofdakker RH, Beersma DG, Bouhuys AL. Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology 1993;113(2):225-30.
    • (1993) Psychopharmacology , vol.113 , Issue.2 , pp. 225-230
    • Van Bemmel, A.L.1    Van den Hoofdakker, R.H.2    Beersma, D.G.3    Bouhuys, A.L.4
  • 266
    • 85203300374 scopus 로고    scopus 로고
    • Prevention of depression recurrence with citalopram: Results from a double-blind, placebo-controlled trial
    • Wade AG, Hochstrasser B. Prevention of depression recurrence with citalopram: Results from a double-blind, placebo-controlled trial. International Journal of Neuropsychopharmacology 2000;3(1):209.
    • (2000) International Journal of Neuropsychopharmacology , vol.3 , Issue.1 , pp. 209
    • Wade, A.G.1    Hochstrasser, B.2
  • 267
    • 33745110292 scopus 로고    scopus 로고
    • Escitalopram in the long-term treatment of major depressive disorder
    • Wade A, Despiegel N, Reines EH. Escitalopram in the long-term treatment of major depressive disorder. Annals of Clinical Psychiatry 2006;18(2):83-9.
    • (2006) Annals of Clinical Psychiatry , vol.18 , Issue.2 , pp. 83-89
    • Wade, A.1    Despiegel, N.2    Reines, E.H.3
  • 268
    • 24444453469 scopus 로고    scopus 로고
    • Citalopram is effective in the treatment of major depressive disorder in children and adolescents: results of a placebo-controlled trial
    • Wagner KD, Robb AS, Findling R, Tiseo P. Citalopram is effective in the treatment of major depressive disorder in children and adolescents: results of a placebo-controlled trial. International Journal of Neuropsychopharmacology 2002;5(1):161.
    • (2002) International Journal of Neuropsychopharmacology , vol.5 , Issue.1 , pp. 161
    • Wagner, K.D.1    Robb, A.S.2    Findling, R.3    Tiseo, P.4
  • 269
    • 85109588567 scopus 로고    scopus 로고
    • Comparative study between citalopram and amitriptyline in treatment of depression induced by Alzheimer Disease
    • Wang X, Hu X, Li H. Comparative study between citalopram and amitriptyline in treatment of depression induced by Alzheimer Disease. Journal of Clinical Psychological Medicine 2005;15(2):84-5.
    • (2005) Journal of Clinical Psychological Medicine , vol.15 , Issue.2 , pp. 84-85
    • Wang, X.1    Hu, X.2    Li, H.3
  • 272
    • 79551532365 scopus 로고    scopus 로고
    • Prophylactic citalopram treatment in hepatitis C patients on antiviral therapy: Will it limit drug-induced depression and enhance adherence?
    • Wise TN. Prophylactic citalopram treatment in hepatitis C patients on antiviral therapy: Will it limit drug-induced depression and enhance adherence?. Current Psychiatry Reports 2011;13:1-2.
    • (2011) Current Psychiatry Reports , vol.13 , pp. 1-2
    • Wise, T.N.1
  • 274
    • 53349173864 scopus 로고    scopus 로고
    • Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population
    • Wu E, Greenberg PE, Yang E, Yu A, Erder MH. Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population. Current Medical Research & Opinion 2008;24:2587-95.
    • (2008) Current Medical Research & Opinion , vol.24 , pp. 2587-2595
    • Wu, E.1    Greenberg, P.E.2    Yang, E.3    Yu, A.4    Erder, M.H.5
  • 275
    • 84970928259 scopus 로고    scopus 로고
    • Comparative study of citalopram combined with amitriptyline for treatment of refractory depression
    • Yang C, Wen Q, Wang X, Liu X. Comparative study of citalopram combined with amitriptyline for treatment of refractory depression. International Medicine and Health Guidance News 2005;11(4):69-70.
    • (2005) International Medicine and Health Guidance News , vol.11 , Issue.4 , pp. 69-70
    • Yang, C.1    Wen, Q.2    Wang, X.3    Liu, X.4
  • 276
    • 77952578080 scopus 로고    scopus 로고
    • Escitalopram: In the treatment of major depressive disorder in adolescent patients
    • Yang LPH, Scott LJ. Escitalopram: In the treatment of major depressive disorder in adolescent patients. Pediatric Drugs 2010;12:155-62.
    • (2010) Pediatric Drugs , vol.12 , pp. 155-162
    • Yang, L.P.H.1    Scott, L.J.2
  • 280
    • 77955294108 scopus 로고    scopus 로고
    • Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial
    • Zisook S, Kasckow JW, Lanouette NM. Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial. Journal of Clinical Psychiatry  2010;71:915-22.
    • (2010) Journal of Clinical Psychiatry , vol.71 , pp. 915-922
    • Zisook, S.1    Kasckow, J.W.2    Lanouette, N.M.3
  • 281
    • 20444440758 scopus 로고    scopus 로고
    • Interventional efficacy of citalopram combined with shining and psychological morning exercise in the attack of depression in elderly people
    • Zou XB, Lin ZX, Lin JD, Lu D, Chen GM. Interventional efficacy of citalopram combined with shining and psychological morning exercise in the attack of depression in elderly people. Chinese Journal of Clinical Rehabilitation 2005;9(12):24-5.
    • (2005) Chinese Journal of Clinical Rehabilitation , vol.9 , Issue.12 , pp. 24-25
    • Zou, X.B.1    Lin, Z.X.2    Lin, J.D.3    Lu, D.4    Chen, G.M.5
  • 282
    • 0023748409 scopus 로고
    • Clinical multicentre study of citalopram compared double-blindly with mianserin in depressed patients in Finland
    • Ahlfors UG, Elovaara S, Harma P, Suoniemi I, Heikkila L, Nummi K, et al. Clinical multicentre study of citalopram compared double-blindly with mianserin in depressed patients in Finland. Nord Psykiatr Tidsskr 1988;42:201-10.
    • (1988) Nord Psykiatr Tidsskr , vol.42 , pp. 201-210
    • Ahlfors, U.G.1    Elovaara, S.2    Harma, P.3    Suoniemi, I.4    Heikkila, L.5    Nummi, K.6
  • 283
    • 85203254063 scopus 로고    scopus 로고
    • The serotonin transporter (SERT) occupancy in median raphe nucleus quantified with PET predicts treatment response to SSRIs in major depressive disorder
    • Akimova E, Lanzenberger R, Savli M, Hausler D, Wadsak W, Spindelegger C. The serotonin transporter (SERT) occupancy in median raphe nucleus quantified with PET predicts treatment response to SSRIs in major depressive disorder. European Neuropsychopharmacology 2010;20:S389.
    • (2010) European Neuropsychopharmacology , vol.20 , pp. S389
    • Akimova, E.1    Lanzenberger, R.2    Savli, M.3    Hausler, D.4    Wadsak, W.5    Spindelegger, C.6
  • 284
    • 85203265607 scopus 로고    scopus 로고
    • Area-specific occupancy of the serotonin transporter by escitalopram and citalopram in major depressive disorder
    • from the 19th European Congress of Psychiatry, EPA 2011 Mar 12-15; Vienna, Austria
    • Akimova E. Area-specific occupancy of the serotonin transporter by escitalopram and citalopram in major depressive disorder. European Psychiatry. 2011; Vol. abstracts from the 19th European Congress of Psychiatry, EPA 2011 Mar 12-15; Vienna, Austria.
    • (2011) European Psychiatry , vol.abstracts
    • Akimova, E.1
  • 285
    • 80052990380 scopus 로고    scopus 로고
    • Effect of citalopram versus escitalopram on quality of life in the treatment of the acute phase of major depressive disorder: A comparative, open-label study
    • Aydemir O, Ergun H, Kesebir S, Soygur H, Tulunay C. Effect of citalopram versus escitalopram on quality of life in the treatment of the acute phase of major depressive disorder: A comparative, open-label study. Klinik Psikofarmakoloji Bulteni 2011;21(3):210-8.
    • (2011) Klinik Psikofarmakoloji Bulteni , vol.21 , Issue.3 , pp. 210-218
    • Aydemir, O.1    Ergun, H.2    Kesebir, S.3    Soygur, H.4    Tulunay, C.5
  • 286
    • 85203240656 scopus 로고    scopus 로고
    • Efficacy analysis of citalopram and amitriptyline in the treatment of depression
    • Du C, Che L. Efficacy analysis of citalopram and amitriptyline in the treatment of depression. Chinese Journal of health Psychology 2004;12(6):424-6.
    • (2004) Chinese Journal of health Psychology , vol.12 , Issue.6 , pp. 424-426
    • Du, C.1    Che, L.2
  • 289
    • 85203265262 scopus 로고    scopus 로고
    • Study on citalopram in the treatment of aged depression
    • Gao B, Yue S, Liu J. Study on citalopram in the treatment of aged depression. Practical Geriatrics 2005;19(1):42-3.
    • (2005) Practical Geriatrics , vol.19 , Issue.1 , pp. 42-43
    • Gao, B.1    Yue, S.2    Liu, J.3
  • 291
    • 85203285556 scopus 로고    scopus 로고
    • A clinical controlled study of citalopram and fluoxetine in the treatment of depression
    • Huang P, Li Z, Wang C. A clinical controlled study of citalopram and fluoxetine in the treatment of depression. Journal of Clinical Psychological Medicine 2004;14(6):364-5.
    • (2004) Journal of Clinical Psychological Medicine , vol.14 , Issue.6 , pp. 364-365
    • Huang, P.1    Li, Z.2    Wang, C.3
  • 292
    • 85041537486 scopus 로고    scopus 로고
    • Contrast study of citalopram and fluoxetine in treatment of depression
    • Huang K. Contrast study of citalopram and fluoxetine in treatment of depression. Modern Medicine and Health 2006;20(10):1456-1457.
    • (2006) Modern Medicine and Health , vol.20 , Issue.10 , pp. 1456-1457
    • Huang, K.1
  • 293
    • 85041491905 scopus 로고    scopus 로고
    • A control study of citalopram and fluoxetine in first-episode senile depression
    • Huang J, Sun Z. A control study of citalopram and fluoxetine in first-episode senile depression. Journal of Clinical Psychosomatic Diseases 2006;12(3):175-6.
    • (2006) Journal of Clinical Psychosomatic Diseases , vol.12 , Issue.3 , pp. 175-176
    • Huang, J.1    Sun, Z.2
  • 294
    • 34249907130 scopus 로고    scopus 로고
    • Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder
    • Juckel G, Pogarell O, Augustin H, Mulert C, Muller-Siecheneder F, Frodl T. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. Journal of Clinical Psychiatry 2007;68:1206-12.
    • (2007) Journal of Clinical Psychiatry , vol.68 , pp. 1206-1212
    • Juckel, G.1    Pogarell, O.2    Augustin, H.3    Mulert, C.4    Muller-Siecheneder, F.5    Frodl, T.6
  • 295
    • 4944238386 scopus 로고    scopus 로고
    • A comparative evaluation on the effect of citalopram and amitriptyline in treating senile depression
    • Li XH, Zhang HW, Pang YD. A comparative evaluation on the effect of citalopram and amitriptyline in treating senile depression. Chinese Journal of Clinical Rehabilitation 2004;8(27):5762-3.
    • (2004) Chinese Journal of Clinical Rehabilitation , vol.8 , Issue.27 , pp. 5762-5763
    • Li, X.H.1    Zhang, H.W.2    Pang, Y.D.3
  • 296
    • 85203291797 scopus 로고    scopus 로고
    • A comparative study of the efficacy of citalopram in the treatment of depression
    • Li X, Sun L, Li Z. A comparative study of the efficacy of citalopram in the treatment of depression. Sichuan Mental Health 2005;18(4):214-6.
    • (2005) Sichuan Mental Health , vol.18 , Issue.4 , pp. 214-216
    • Li, X.1    Sun, L.2    Li, Z.3
  • 297
    • 33748471386 scopus 로고    scopus 로고
    • The effectiveness and safety of escitalopram in the treatment of major depression: A randomized double-blind active-drug controlled trial
    • Li J, Shen WW, Liu Y, Xu L, Liu SM, Kuang WH. The effectiveness and safety of escitalopram in the treatment of major depression: A randomized double-blind active-drug controlled trial. Chinese Journal of Evidence-Based Medicine 2006;6(8):552-6.
    • (2006) Chinese Journal of Evidence-Based Medicine , vol.6 , Issue.8 , pp. 552-556
    • Li, J.1    Shen, W.W.2    Liu, Y.3    Xu, L.4    Liu, S.M.5    Kuang, W.H.6
  • 298
    • 85041517808 scopus 로고    scopus 로고
    • A comparative study of citalopram and fluoxetine in the treatment of depression
    • Liang C, Liu L, Zhang X. A comparative study of citalopram and fluoxetine in the treatment of depression. Shandong Archives of Psychiatry 2005;18(2):82-3.
    • (2005) Shandong Archives of Psychiatry , vol.18 , Issue.2 , pp. 82-83
    • Liang, C.1    Liu, L.2    Zhang, X.3
  • 299
    • 85203235935 scopus 로고    scopus 로고
    • Comparative study of citalopram and mianserin in the treatment of senile depression
    • Liang K, Fan X. Comparative study of citalopram and mianserin in the treatment of senile depression. Journal of Clinical Psychological Medicine 2006;16(1):32-3.
    • (2006) Journal of Clinical Psychological Medicine , vol.16 , Issue.1 , pp. 32-33
    • Liang, K.1    Fan, X.2
  • 300
    • 85041724082 scopus 로고    scopus 로고
    • A comparative study of citalopram and paroxetine in the treatment of depression
    • Li DS, Wang C, Yu J. A comparative study of citalopram and paroxetine in the treatment of depression. Medical Journal of Chinese People's Health 2006;18(6):460-1.
    • (2006) Medical Journal of Chinese People's Health , vol.18 , Issue.6 , pp. 460-461
    • Li, D.S.1    Wang, C.2    Yu, J.3
  • 302
    • 85203299728 scopus 로고    scopus 로고
    • A control study on citalopram and amitriptyline in the treatment of aged patients with depression
    • Liu J, Gan L, Feng D. A control study on citalopram and amitriptyline in the treatment of aged patients with depression. China Journal of Health Psychology 2006;14(4):450-1.
    • (2006) China Journal of Health Psychology , vol.14 , Issue.4 , pp. 450-451
    • Liu, J.1    Gan, L.2    Feng, D.3
  • 304
    • 85203265109 scopus 로고    scopus 로고
    • Comparative study of citalopram and venlafaxine in the treatment of depression
    • Li D, Yu J, Pang Y. Comparative study of citalopram and venlafaxine in the treatment of depression. Journal of Clinical Psychological Medicine 2005;15(3):158-9.
    • (2005) Journal of Clinical Psychological Medicine , vol.15 , Issue.3 , pp. 158-159
    • Li, D.1    Yu, J.2    Pang, Y.3
  • 305
    • 85203275780 scopus 로고    scopus 로고
    • Clinical controlled study of citalopram versus amitriptyline in treatment of depressive disorder
    • Li Z, Zeng Z, Liu Q. Clinical controlled study of citalopram versus amitriptyline in treatment of depressive disorder. Sichuan Mental Health 2004;17(2):76-8.
    • (2004) Sichuan Mental Health , vol.17 , Issue.2 , pp. 76-78
    • Li, Z.1    Zeng, Z.2    Liu, Q.3
  • 306
    • 85203288486 scopus 로고    scopus 로고
    • Controlled study of citalopram versus amitriptyline in treatment of depressive disorder
    • Lu Q, Li Z, Zeng Z. Controlled study of citalopram versus amitriptyline in treatment of depressive disorder. Journal of Clinical Psychological Medicine 2008;18:69-70.
    • (2008) Journal of Clinical Psychological Medicine , vol.18 , pp. 69-70
    • Lu, Q.1    Li, Z.2    Zeng, Z.3
  • 307
    • 85203264005 scopus 로고    scopus 로고
    • A comparative study of citalopram and amitriptyline in the treatment of depression
    • Ma Z, Zheng Z, Zhuang X. A comparative study of citalopram and amitriptyline in the treatment of depression. Shandong Archives of Psychiatry 2004;17(2):79-81.
    • (2004) Shandong Archives of Psychiatry , vol.17 , Issue.2 , pp. 79-81
    • Ma, Z.1    Zheng, Z.2    Zhuang, X.3
  • 308
    • 0022634450 scopus 로고
    • Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study
    • Moeller SE, de Beurs P, Timmerman L, Tan BK, Leijnse-Ybema HJ, Cohen Stuart MH, et al. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study. Psychopharmacology 1986;5:96-100.
    • (1986) Psychopharmacology , vol.5 , pp. 96-100
    • Moeller, S.E.1    de Beurs, P.2    Timmerman, L.3    Tan, B.K.4    Leijnse-Ybema, H.J.5    Cohen Stuart, M.H.6
  • 309
    • 85203252576 scopus 로고    scopus 로고
    • Phase 4 Study of Clinical Pharmacogenomics of Antidepressant Response
    • http://clinicaltrials.gov/ct2/show/NCT00269334 accessed 11 Jun 2012 [NCT00269334]
    • Chen W, Deng C, Liu J-Y, Hsiao N, Wen J-K, Wu C-K. Phase 4 Study of Clinical Pharmacogenomics of Antidepressant Response. ClinicalTrials.gov [www.clinicaltrials.gov] 2005:http://clinicaltrials.gov/ct2/show/NCT00269334 (accessed 11 Jun 2012). [NCT00269334]
    • (2005) ClinicalTrials.gov [www.clinicaltrials.gov]
    • Chen, W.1    Deng, C.2    Liu, J.-Y.3    Hsiao, N.4    Wen, J.-K.5    Wu, C.-K.6
  • 311
    • 85203263852 scopus 로고    scopus 로고
    • Mismatch negativity in depressed patients under selective noradrenergic and serotonergic antidepressants
    • Norra C, Peddersen A, Juckel G, Waniek S. Mismatch negativity in depressed patients under selective noradrenergic and serotonergic antidepressants. European Neuropsychopharmacology 2011;21(Suppl 3):251-2.
    • (2011) European Neuropsychopharmacology , vol.21 , pp. 251-252
    • Norra, C.1    Peddersen, A.2    Juckel, G.3    Waniek, S.4
  • 312
    • 27644520431 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of depression treatment with paroxetine, venlafaxine and citalopram
    • Pan K, Liu X, Yang J, Zhu L, Wang X, Wang X, et al. Cost-effectiveness analysis of depression treatment with paroxetine, venlafaxine and citalopram. Chinese Journal of Clinical rehabilitation 2005;9(28):16-7.
    • (2005) Chinese Journal of Clinical rehabilitation , vol.9 , Issue.28 , pp. 16-17
    • Pan, K.1    Liu, X.2    Yang, J.3    Zhu, L.4    Wang, X.5    Wang, X.6
  • 313
    • 85041736081 scopus 로고    scopus 로고
    • Comparative study of citalopram and paroxetine in treatment of depression
    • Qiao J, Yu J, Hao Z. Comparative study of citalopram and paroxetine in treatment of depression. Journal of Clinical Psychological Medicine 2005;15(5):281-2.
    • (2005) Journal of Clinical Psychological Medicine , vol.15 , Issue.5 , pp. 281-282
    • Qiao, J.1    Yu, J.2    Hao, Z.3
  • 315
    • 85203298629 scopus 로고    scopus 로고
    • Controlled study of citalopram and sertraline the treatment of depression
    • Ren Y. Controlled study of citalopram and sertraline the treatment of depression. Medical Journal of Chinese People's Health 2006;18(7):580-1.
    • (2006) Medical Journal of Chinese People's Health , vol.18 , Issue.7 , pp. 580-581
    • Ren, Y.1
  • 317
    • 85203237865 scopus 로고    scopus 로고
    • Comparative study of citalopram and maprotiline in treatment of depression
    • Shi Y, Liu H, Ding D. Comparative study of citalopram and maprotiline in treatment of depression. Journal of Clinical Psychological Medicine 2005;15(6):356-7.
    • (2005) Journal of Clinical Psychological Medicine , vol.15 , Issue.6 , pp. 356-357
    • Shi, Y.1    Liu, H.2    Ding, D.3
  • 318
    • 85203237692 scopus 로고    scopus 로고
    • Comparisons of citalopram and fluoxetine in first-episode depression
    • Song H, Guo B, Chen Z. Comparisons of citalopram and fluoxetine in first-episode depression. Journal of Clinical Psychosomatic Disease 2004;10(3):180-1.
    • (2004) Journal of Clinical Psychosomatic Disease , vol.10 , Issue.3 , pp. 180-181
    • Song, H.1    Guo, B.2    Chen, Z.3
  • 319
    • 85203282668 scopus 로고    scopus 로고
    • A double blind study of citalopram and amitriptyline in the treatment of aged depression
    • Tan X, Li H, Du Z. A double blind study of citalopram and amitriptyline in the treatment of aged depression. Shandong Archives of Psychiatry 2004;17(4):202-3.
    • (2004) Shandong Archives of Psychiatry , vol.17 , Issue.4 , pp. 202-203
    • Tan, X.1    Li, H.2    Du, Z.3
  • 320
    • 85203275552 scopus 로고    scopus 로고
    • Efficacy of citalopram and amitriptyline in the treatment of patients with depression
    • Tang W, Huang W. Efficacy of citalopram and amitriptyline in the treatment of patients with depression. Shangai Archives of Psychiatry 2005;17(2):87-8.
    • (2005) Shangai Archives of Psychiatry , vol.17 , Issue.2 , pp. 87-88
    • Tang, W.1    Huang, W.2
  • 321
    • 85041730783 scopus 로고    scopus 로고
    • A comparative study between citalopram and paroxetine in the treatment of depression
    • Tao W, LV C, Li W. A comparative study between citalopram and paroxetine in the treatment of depression. Medical Journal of Chinese People's Health 2005;17(9):491-2.
    • (2005) Medical Journal of Chinese People's Health , vol.17 , Issue.9 , pp. 491-492
    • Tao, W.1    Lv, C.2    Li, W.3
  • 322
    • 45549098108 scopus 로고    scopus 로고
    • GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
    • Thomas L, Mulligan J, Mason V, Tallon D, Wiles N, Cowen P, et al. GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol. Trials 2008;9(29):1-10.
    • (2008) Trials , vol.9 , Issue.29 , pp. 1-10
    • Thomas, L.1    Mulligan, J.2    Mason, V.3    Tallon, D.4    Wiles, N.5    Cowen, P.6
  • 323
    • 85203246761 scopus 로고    scopus 로고
    • A control study of citalopram in the treatment of senile depression
    • Wan Y, Li M, Han Y. A control study of citalopram in the treatment of senile depression. Journal of Clinical Psychosomatic Diseases 2006;12(4):243-4.
    • (2006) Journal of Clinical Psychosomatic Diseases , vol.12 , Issue.4 , pp. 243-244
    • Wan, Y.1    Li, M.2    Han, Y.3
  • 324
    • 85203252171 scopus 로고    scopus 로고
    • A double-blind control study on the effect of citalopram and imipramine on depression
    • Wang X. A double-blind control study on the effect of citalopram and imipramine on depression. Modern Forums in Basic 2003;7(12):1111-2.
    • (2003) Modern Forums in Basic , vol.7 , Issue.12 , pp. 1111-1112
    • Wang, X.1
  • 326
    • 85203278854 scopus 로고    scopus 로고
    • Comparative study of citalopram vs mirtazapine in treatment of senile depressive patients
    • Wang J, Yang C, Wang Y. Comparative study of citalopram vs mirtazapine in treatment of senile depressive patients. China Journal of Health Psychology 2006;14(5):552-3.
    • (2006) China Journal of Health Psychology , vol.14 , Issue.5 , pp. 552-553
    • Wang, J.1    Yang, C.2    Wang, Y.3
  • 327
    • 85203270275 scopus 로고    scopus 로고
    • A comparative study of citalopram and amitriptyline in the treatment of out-patients with depression
    • Xu M, Ji L. A comparative study of citalopram and amitriptyline in the treatment of out-patients with depression. Chinese Mental Health Journal 2005;19(5):353-4.
    • (2005) Chinese Mental Health Journal , vol.19 , Issue.5 , pp. 353-354
    • Xu, M.1    Ji, L.2
  • 328
    • 85203246317 scopus 로고    scopus 로고
    • Controlled study of citalopram and venlafaxine in treatment of patients with senile depression
    • Yu J, Wang P, Zhang G, Hao Z. Controlled study of citalopram and venlafaxine in treatment of patients with senile depression. Journal of Clinical Psychological Medicine 2006;16(2):92-3.
    • (2006) Journal of Clinical Psychological Medicine , vol.16 , Issue.2 , pp. 92-93
    • Yu, J.1    Wang, P.2    Zhang, G.3    Hao, Z.4
  • 330
    • 85203250730 scopus 로고    scopus 로고
    • A study of citalopram in treatment of old age depression
    • Zhang F, Mao Q. A study of citalopram in treatment of old age depression. Chinese Journal of Clinical Rehabilitation 2006;14(4):434-5.
    • (2006) Chinese Journal of Clinical Rehabilitation , vol.14 , Issue.4 , pp. 434-435
    • Zhang, F.1    Mao, Q.2
  • 331
    • 85041510840 scopus 로고    scopus 로고
    • A control study in the treatment of depressive disorder with citalopram and fluoxetine
    • Zhao H, Guan T. A control study in the treatment of depressive disorder with citalopram and fluoxetine. Evaluation and Analysis of Drug-Use in Hospitals of China 2006;6(2):106-8.
    • (2006) Evaluation and Analysis of Drug-Use in Hospitals of China , vol.6 , Issue.2 , pp. 106-108
    • Zhao, H.1    Guan, T.2
  • 333
    • 85203284346 scopus 로고    scopus 로고
    • Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
    • http://clinicaltrials.gov/ct2/show/NCT01407094?term=NCT01407094&rank=1. accessed 11 Jun 2012
    • Trivedi M H, McGrath P J, Weissman M, Parsey R, Fava M. Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression. ClinicalTrials.gov 2011; Vol. NCT01407094:http://clinicaltrials.gov/ct2/show/NCT01407094?term=NCT01407094&rank=1. (accessed 11 Jun 2012).
    • (2011) ClinicalTrials.gov , vol.NCT01407094
    • Trivedi, M.H.1    McGrath, P.J.2    Weissman, M.3    Parsey, R.4    Fava, M.5
  • 334
    • 85203239272 scopus 로고    scopus 로고
    • A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder
    • http://clinicaltrials.gov/ct2/show/NCT01473381?term=NCT01473381&rank=1. accessed 11 Jun 2012 [Forest VLZ-MD-01]
    • Forest Laboratories. A Double-Blind, Placebo- and Active-Controlled, Fixed-Dose Study of Vilazodone in Patients With Major Depressive Disorder. ClinicalTrials.gov 2011:http://clinicaltrials.gov/ct2/show/NCT01473381?term=NCT01473381&rank=1. (accessed 11 Jun 2012). [Forest VLZ-MD-01]
    • (2011) ClinicalTrials.gov
    • Forest, L.1
  • 335
    • 0043198131 scopus 로고    scopus 로고
    • Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
    • Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA 2003;290(7):921-8.
    • (2003) JAMA , vol.290 , Issue.7 , pp. 921-928
    • Als-Nielsen, B.1    Chen, W.2    Gluud, C.3    Kjaergard, L.L.4
  • 336
    • 33744666102 scopus 로고    scopus 로고
    • Detecting skewness from summary information
    • Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313(7066):1200.
    • (1996) BMJ , vol.313 , Issue.7066 , pp. 1200
    • Altman, D.G.1    Bland, J.M.2
  • 337
  • 338
    • 0034030898 scopus 로고    scopus 로고
    • Practice guideline for the treatment of patients with major depressive disorder (revision)
    • American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). American Journal of Psychiatry 2000;157(4 Suppl):1-45.
    • (2000) American Journal of Psychiatry , vol.157 , Issue.4 , pp. 1-45
  • 342
    • 0000358207 scopus 로고
    • Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs
    • Bloom FE, Kupfer DJ, editor(s)., New York, Raven Press
    • Barker EL, Blakely RD. Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs. In: Bloom FE, Kupfer DJ editor(s). Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, 1995:321–34.
    • (1995) Psychopharmacology: The Fourth Generation of Progress , pp. 321-334
    • Barker, E.L.1    Blakely, R.D.2
  • 343
    • 9444255722 scopus 로고    scopus 로고
    • Improving the quality of randomized controlled trials. The CONSORT statement
    • Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-9.
    • (1996) JAMA , vol.276 , pp. 637-639
    • Begg, C.1    Cho, M.2    Eastwood, S.3    Horton, R.4    Moher, D.5    Olkin, I.6
  • 344
    • 10744230594 scopus 로고    scopus 로고
    • Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials
    • Bhandari M, Busse JW, Jackowski D, Montori VM, Schunemann H, Sprague S, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Canadian Medical Association Journal 2004;170(4):477-80.
    • (2004) Canadian Medical Association Journal , vol.170 , Issue.4 , pp. 477-480
    • Bhandari, M.1    Busse, J.W.2    Jackowski, D.3    Montori, V.M.4    Schunemann, H.5    Sprague, S.6
  • 345
    • 0032901648 scopus 로고    scopus 로고
    • Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials
    • Bollini P, Pampallona S, Tibaldi G, Kupelnick B, Munizza C. Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials. British Journal of Psychiatry 1999;174:297-303.
    • (1999) British Journal of Psychiatry , vol.174 , pp. 297-303
    • Bollini, P.1    Pampallona, S.2    Tibaldi, G.3    Kupelnick, B.4    Munizza, C.5
  • 346
    • 1542639514 scopus 로고    scopus 로고
    • Industry sponsorship and authorship of clinical trials over 20 years
    • Buchkowsky SS, Jewesson PJ. Industry sponsorship and authorship of clinical trials over 20 years. Annals of Pharmacotherapy 2004;38(4):579-85.
    • (2004) Annals of Pharmacotherapy , vol.38 , Issue.4 , pp. 579-585
    • Buchkowsky, S.S.1    Jewesson, P.J.2
  • 348
    • 13844320384 scopus 로고    scopus 로고
    • Suicide, depression, and antidepressants
    • Cipriani A, Barbui C, Geddes JR. Suicide, depression, and antidepressants. BMJ 2005;330(7488):373-4.
    • (2005) BMJ , vol.330 , Issue.7488 , pp. 373-374
    • Cipriani, A.1    Barbui, C.2    Geddes, J.R.3
  • 350
    • 33846859566 scopus 로고    scopus 로고
    • Venlafaxine for major depression
    • Cipriani A, Geddes JR, Barbui C. Venlafaxine for major depression. BMJ 2007;334(7587):215-6.
    • (2007) BMJ , vol.334 , Issue.7587 , pp. 215-216
    • Cipriani, A.1    Geddes, J.R.2    Barbui, C.3
  • 351
    • 60849086169 scopus 로고    scopus 로고
    • Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments metaanalysis
    • Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments metaanalysis. Lancet 2009;373:746–58.
    • (2009) Lancet , vol.373 , pp. 746-758
    • Cipriani, A.1    Furukawa, T.A.2    Salanti, G.3    Geddes, J.R.4    Higgins, J.P.5    Churchill, R.6
  • 354
    • 70449698757 scopus 로고    scopus 로고
    • Why internal and external validity of experimental studies are relevant for clinical practice?
    • Cipriani A, Purgato M, Barbui C. Why internal and external validity of experimental studies are relevant for clinical practice?. Epidemiology and Psychiatric Sciences 2009;18(2):101-3.
    • (2009) Epidemiology and Psychiatric Sciences , vol.18 , Issue.2 , pp. 101-103
    • Cipriani, A.1    Purgato, M.2    Barbui, C.3
  • 360
    • 0036208463 scopus 로고    scopus 로고
    • Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses
    • Furukawa TA, Guyatt GH, Griffith LE. Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. International Journal of Epidemiology 2002;31(1):72-6.
    • (2002) International Journal of Epidemiology , vol.31 , Issue.1 , pp. 72-76
    • Furukawa, T.A.1    Guyatt, G.H.2    Griffith, L.E.3
  • 361
    • 0037010355 scopus 로고    scopus 로고
    • Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review
    • Furukawa TA, McGuire H, Barbui C. Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. BMJ 2002;325(7371):991-5.
    • (2002) BMJ , vol.325 , Issue.7371 , pp. 991-995
    • Furukawa, T.A.1    McGuire, H.2    Barbui, C.3
  • 365
    • 77955605942 scopus 로고    scopus 로고
    • Differences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella review
    • Gartlehner G, Chapman A, Strobelberger M, Thaler K. Differences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella review. PLoS One 2010;5(7):e11895.
    • (2010) PLoS One , vol.5 , Issue.7
    • Gartlehner, G.1    Chapman, A.2    Strobelberger, M.3    Thaler, K.4
  • 366
    • 82855181115 scopus 로고    scopus 로고
    • Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis
    • Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Annals of Internal Medicine 2011;155(11):772-85.
    • (2011) Annals of Internal Medicine , vol.155 , Issue.11 , pp. 772-785
    • Gartlehner, G.1    Hansen, R.A.2    Morgan, L.C.3    Thaler, K.4    Lux, L.5    Van Noord, M.6
  • 367
    • 4944265612 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitors
    • Geddes JR, Cipriani A. Selective serotonin reuptake inhibitors. BMJ 2004;329(7470):809-10.
    • (2004) BMJ , vol.329 , Issue.7470 , pp. 809-810
    • Geddes, J.R.1    Cipriani, A.2
  • 368
    • 42749090279 scopus 로고    scopus 로고
    • Antidepressants and their onset of action: a major clinical, methodological and pronostical issue
    • Gourion D. Antidepressants and their onset of action: a major clinical, methodological and pronostical issue. Encéphale 2008;34(1):73–81.
    • (2008) Encéphale , vol.34 , Issue.1 , pp. 73-81
    • Gourion, D.1
  • 369
    • 0003412404 scopus 로고
    • Revised, Rockville MD, U.S. Department of Health, EducationWelfare, Public Health Service, Alcohol, Drug AbuseMental Health Administration, NIMH
    • Guy W. Clinical Global Impressions - ECDEU Asessment Manual Psychopharmacology (DHEW Publ No ADM 76-338). Revised. Rockville MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH, 1976.
    • (1976) Clinical Global Impressions - ECDEU Asessment Manual Psychopharmacology (DHEW Publ No ADM 76-338)
    • Guy, W.1
  • 370
    • 0029063759 scopus 로고
    • Global Assessment of Functioning - a modified scale
    • Hall RC. Global Assessment of Functioning - a modified scale. Psychosomatics 1995;36:267-75.
    • (1995) Psychosomatics , vol.36 , pp. 267-275
    • Hall, R.C.1
  • 372
    • 0041876133 scopus 로고    scopus 로고
    • Measuring inconsistency in meta-analyses
    • Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
    • (2003) BMJ , vol.327 , Issue.7414 , pp. 557-560
    • Higgins, J.P.1    Thompson, S.G.2    Deeks, J.J.3    Altman, D.G.4
  • 375
    • 33846563409 scopus 로고    scopus 로고
    • Why most published research findings are false
    • Ioannidis JP. Why most published research findings are false. PLoS Medicine 2005;2:e124.
    • (2005) PLoS Medicine , vol.2
    • Ioannidis, J.P.1
  • 376
    • 0038014050 scopus 로고    scopus 로고
    • Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administration summary basis of approval reports
    • Khan A, Khan SR, Walens G, Kolts R, Giller EL. Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administration summary basis of approval reports. Neuropsychopharmacology 2003;28(3):552-7.
    • (2003) Neuropsychopharmacology , vol.28 , Issue.3 , pp. 552-557
    • Khan, A.1    Khan, S.R.2    Walens, G.3    Kolts, R.4    Giller, E.L.5
  • 377
    • 77955169816 scopus 로고    scopus 로고
    • Escitalopram - translating molecular properties into clinical benefit: reviewing the evidence in major depression
    • Leonard B, Taylor D. Escitalopram - translating molecular properties into clinical benefit: reviewing the evidence in major depression. The Journal of Psychopharmacology 2010;24(8):1143-52.
    • (2010) The Journal of Psychopharmacology , vol.24 , Issue.8 , pp. 1143-1152
    • Leonard, B.1    Taylor, D.2
  • 378
    • 0038439242 scopus 로고    scopus 로고
    • Pharmaceutical industry sponsorship and research outcome and quality: systematic review
    • Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326(7400):1167-70.
    • (2003) BMJ , vol.326 , Issue.7400 , pp. 1167-1170
    • Lexchin, J.1    Bero, L.A.2    Djulbegovic, B.3    Clark, O.4
  • 380
    • 0018425438 scopus 로고
    • A new depression scale designed to be sensitive to change
    • Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382-9.
    • (1979) British Journal of Psychiatry , vol.134 , pp. 382-389
    • Montgomery, S.A.1    Asberg, M.2
  • 381
    • 9944249164 scopus 로고    scopus 로고
    • An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia
    • Montgomery JH, Byerly M, Carmody T, Li B, Miller DR, Varghese F, et al. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia. Controlled Clinical Trials 2004;25(6):598-612.
    • (2004) Controlled Clinical Trials , vol.25 , Issue.6 , pp. 598-612
    • Montgomery, J.H.1    Byerly, M.2    Carmody, T.3    Li, B.4    Miller, D.R.5    Varghese, F.6
  • 383
    • 19244374612 scopus 로고    scopus 로고
    • Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS)
    • Müller M J, Himmerich H, Kienzle B, Szegedi A. Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS). Journal of Affective Disorders 2003;77(3):255-60.
    • (2003) Journal of Affective Disorders , vol.77 , Issue.3 , pp. 255-260
    • Müller, M.J.1    Himmerich, H.2    Kienzle, B.3    Szegedi, A.4
  • 388
    • 26444530107 scopus 로고    scopus 로고
    • Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry
    • Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, Nierenberg AA. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. American Journal of Psychiatry 2005;162(10):1957-60.
    • (2005) American Journal of Psychiatry , vol.162 , Issue.10 , pp. 1957-1960
    • Perlis, R.H.1    Perlis, C.S.2    Wu, Y.3    Hwang, C.4    Joseph, M.5    Nierenberg, A.A.6
  • 389
  • 390
    • 11444261579 scopus 로고    scopus 로고
    • External validity of randomised controlled trials: to whom do the results apply?
    • Rothwell PM. External validity of randomised controlled trials: to whom do the results apply?. Lancet 2005;365:82–93.
    • (2005) Lancet , vol.365 , pp. 82-93
    • Rothwell, P.M.1
  • 392
    • 85047692188 scopus 로고
    • Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
    • Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
    • (1995) JAMA , vol.273 , Issue.5 , pp. 408-412
    • Schulz, K.F.1    Chalmers, I.2    Hayes, R.J.3    Altman, D.G.4
  • 394
    • 0028102141 scopus 로고
    • Is serotonin receptor desensitization linked to the mechanism of action of antidepressant drugs?
    • Stahl SM. Is serotonin receptor desensitization linked to the mechanism of action of antidepressant drugs?. Psychopharmacology Bulletin 1994;30:39–43.
    • (1994) Psychopharmacology Bulletin , vol.30 , pp. 39-43
    • Stahl, S.M.1
  • 395
    • 0032440963 scopus 로고    scopus 로고
    • Mechanism of action of serotonin selective reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects and side effects
    • Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects and side effects. Journal of Affective Disorders 1998;51(3):215-35.
    • (1998) Journal of Affective Disorders , vol.51 , Issue.3 , pp. 215-235
    • Stahl, S.M.1
  • 396
    • 0033667445 scopus 로고    scopus 로고
    • Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature
    • [PUBMED 11106885]
    • Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. Journal of Clinical Epidemiology 2000;53(11):1119-29. [PUBMED: 11106885]
    • (2000) Journal of Clinical Epidemiology , vol.53 , Issue.11 , pp. 1119-1129
    • Sterne, J.A.1    Gavaghan, D.2    Egger, M.3
  • 397
    • 0030819527 scopus 로고    scopus 로고
    • Symptom profiles of depression among general medical service users compared with specialty mental health service users
    • Suh T, Gallo J J. Symptom profiles of depression among general medical service users compared with specialty mental health service users. Psychological Medicine 1997;27(5):1051-63.
    • (1997) Psychological Medicine , vol.27 , Issue.5 , pp. 1051-1063
    • Suh, T.1    Gallo, J.J.2
  • 398
    • 33750694210 scopus 로고    scopus 로고
    • Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis
    • Taylor M J, Freemantle N, Geddes J R, Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Archives of General Psychiatry 2006;63(11):1217-23.
    • (2006) Archives of General Psychiatry , vol.63 , Issue.11 , pp. 1217-1223
    • Taylor, M.J.1    Freemantle, N.2    Geddes, J.R.3    Bhagwagar, Z.4
  • 399
  • 400
    • 0026877917 scopus 로고
    • The MOS 36-item short form health survey (SF-36)
    • Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36). Medical Care 1992;30:473-83.
    • (1992) Medical Care , vol.30 , pp. 473-483
    • Ware, J.E.1    Sherbourne, C.D.2
  • 403
    • 85203266079 scopus 로고    scopus 로고
    • WHO Collaborative Centre for Drug Statistics Methodology
    • World Health Organization. WHO Collaborative Centre for Drug Statistics Methodology. http://www.whocc.no/atcddd/.
    • http://www.whocc.no/atcddd/
  • 404
    • 85203299312 scopus 로고    scopus 로고
    • ATC/DDD Index 2009
    • WHO Collaborative Centre for Drug Statistics Methodology. ATC/DDD Index 2009. http://www.whocc.no/atcddd/ 2009.
    • (2009) http://www.whocc.no/atcddd/
  • 405
    • 0032526912 scopus 로고    scopus 로고
    • The World Health Organization quality of life assessment (WHOQOL): Development and general psychometric properties
    • WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): Development and general psychometric properties. Social Science and Medicine 1998;46(12):1569-85.
    • (1998) Social Science and Medicine , vol.46 , Issue.12 , pp. 1569-1585
  • 407
    • 40949113623 scopus 로고    scopus 로고
    • Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
    • Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336(7644):601-5.
    • (2008) BMJ , vol.336 , Issue.7644 , pp. 601-605
    • Wood, L.1    Egger, M.2    Gluud, L.L.3    Schulz, K.F.4    Jüni, P.5    Altman, D.G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.